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INTRODUCTION 
 
I. RNA Polymerase II-Dependent Transcription 
There are three highly conserved RNA polymerases in eukaryotes that collectively 
are responsible for the transcription of all classes of cellular RNA.  One of these 
enzymes, RNA polymerase II (RNAPII), is responsible for transcribing DNA to mRNA 
as well as most snRNAs and miRNAs.  RNAPII is a large, 550 KDa complex that 
consists of 12 protein subunits known as Rpb1 through Rpb12 (Figure 1), several of 
which have conserved homologs in the eukaryotic polymerases RNAPI and RNAPIII 
(Cramer et al., 2008).  In addition to its subunits, a wide variety of sequence specific and 
general transcription factors are required for RNAPII to bind to a promoter, form a 
competent initiation complex, and to modulate gene-specific messenger RNA (mRNA) 
transcript levels in response to environmental and developmental signals (Nikolov and 
Burley, 1997).   
During RNA transcription in eukaryotes, nascent mRNA is processed at its 5’ and 3’-
ends and is often spliced, reviewed in (Kuehner et al., 2011).  These processing steps are 
closely coupled to RNAPII transcription through a variety of mechanisms, one of which 
involves the recruitment of specific sets of RNA processing factors to specific modified 
forms of the C-terminal domain (CTD) of Rpb1, the largest subunit of RNAPII, reviewed 
in (Buratowski, 2009).  The CTD of Rpb1 in yeast consists of 26-27 repeats of the 
sequence Y1S2P3T4S5P6S7, which serves as a signaling platform that is unique to RNAPII 
(Corden et al., 1985).  Specifically, serine-2 (S2), serine-5 (S5), and serine-7 (S7) of the 
CTD repeat are subject to phosphorylation by cellular kinases, and the pattern of serine 
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phosphorylation is specific for a given stage of transcription in the yeast Saccharomyces 
cerevisiae (S. cerevisiae) (Akhtar et al., 2009; Chapman et al., 2007; Kim et al., 2009; 
Komarnitsky et al., 2000).  It is through this mechanism; the stage-specific 
phosphorylation of S2, S5, and S7, that information about the location of RNAPII relative 
to the target gene is encoded in the CTD and is used to recruit accessory proteins at the 
proper time during transcription. 
 
 
Figure 1.  Ribbon structure of Saccharomyces cerevisiae RNA polymerase II. 
 
RNAPII must exist in a hypophosphorylated state before a viable initiation complex 
can be formed at the promoter of a target gene (Laybourn and Dahmus, 1990; Lu et al., 
1991).  Immediately following the formation of the initiation complex, there is an 
increase in the level of serine-5 phosphorylation (S5-P), which is responsible for 
recruiting the 5’-capping machinery (Fabrega et al., 2003; Komarnitsky et al., 2000; 
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Schroeder et al., 2000).  As transcription proceeds into elongation, there is a change in 
the CTD phosphorylation pattern that results in increases in S2-P (Cho et al., 2001).  The 
phosphorylation of S2 is especially important as transcription nears termination because 
S2-P serves as a binding site for the termination and polyadenylation machinery to 
interact with the CTD (Kim et al., 2004; Licatalosi et al., 2002; Meinhart and Cramer, 
2004).   
 
II. Additional Proteins Involved in the Regulation of RNAPII Activity 
In addition to the subunits of RNAPII, numerous other proteins are involved in the 
regulation of transcription.  These factors respond to a wide range of cellular signals that 
relay information about the cell’s environment (e.g. oxidative and heat stress), state of 
nutrition, and proliferation status back to the transcription machinery (Mager and De 
Kruijff, 1995).  The role of transcription complexes such as Mediator, Elongator, and 
SAGA, for example, have been previously reviewed (Bhaumik, 2011; Casamassimi and 
Napoli, 2007; Creppe and Buschbeck, 2011); however, a detailed understanding of the 
kinases and phosphatases that are involved in the regulation of transcription through their 
role in mediating the phosphorylation state of the CTD is less clear. 
Our current working model of transcription (Figure 2) shows RNAPII at the promoter 
of a target gene during transcription initiation.  Successively, the Kin28 subunit of the 
general transcription factor TFIIH phosphorylates S5 of the CTD, which recruits the 
capping machinery and initiates mRNA processing as RNAPII is released from the 
promoter and moves into the coding region of the gene (Komarnitsky et al., 2000; 
Schroeder et al., 2000).  In addition to phosphorylating S5, TFIIH has been shown to 
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phosphorylate S7 in vitro and was also proven to be necessary for S7-P in vivo (Akhtar et 
al., 2009; Kim et al., 2009).  During transcription elongation, the Ctk1 subunit of the 
CTDK-I complex catalyzes the phosphorylation of CTD S2 (Cho et al., 2001), and it is 
this increase in S2-P that recruits specific members of the termination and 
polyadenylation machinery as RNAPII approaches the 3’-end of the target gene (Kim et 
al., 2009; Licatalosi et al., 2002; Meinhart and Cramer, 2004).  Additionally, the cyclin-
dependent kinase Bur1 was shown to phosphorylate CTD S2 near target gene promoters 
and was also shown to stimulate CTDK-I mediated S2-P during transcription elongation 
(Qiu et al., 2009). 
During the transcription cycle, the transition from CTD S5-P to S2-P is affected by 
the aforementioned kinases as well as by the opposing action of CTD-phosphatases.  
Three CTD phosphatases have been characterized in yeast that remove S2, S5, and S7 
phosphorylation (Bataille et al., 2012; Kobor et al., 1999; Meinhart and Cramer, 2004; 
Mosley et al., 2009; Zhang et al., 2012).  The first characterized phosphatase, Fcp1, has 
been shown to dephosphorylate S2-P during the transcription cycle and may play a role in 
recycling RNAPII by converting it back to its hypophosphorylated state following 
transcription termination (Archambault et al., 1997; Aygun et al., 2008; Chambers et al., 
1995; Cho et al., 2001; Kobor et al., 1999; Kong et al., 2005). 
The phosphatase Ssu72 removes S5-P from the RNAPII CTD (Krishnamurthy et al., 
2004) and has recently been characterized as a S7-P phosphatase (Kobor et al., 1999; 
Zhang et al., 2012).   Ssu72 is enriched at the 3’-end of RNAPII target genes where it 
functions as a subunit of the cleavage and polyadenylation factor (CPF) complex (He et 
al., 2003) and is consequently also involved mRNA 3’ end processing (He et al., 2003).  
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However, Ssu72 phosphatase activity has been shown to be independent of its role in 
dephosphorylating S5-P (Krishnamurthy et al., 2004). The involvement of Ssu72 in the 
later stages of transcription is supported by one, evidence that Ssu72 enrichment at the 
promoter is low if not absent as determined by Chromatin Immunoprecipitation (ChIP) 
experiments (Ansari and Hampsey, 2005; Nedea et al., 2003) and two, that Ssu72 
temperature sensitive mutants show defects in transcription termination (Steinmetz and 
Brow, 2003).  Furthermore, Ssu72 was recently shown to recognize the S5-P-cis-proline-
6 isomer, and the cis/trans isomerization reaction catalyzed by the proline isomerase Ess1 
was shown to facilitate the dephosphorylation of S5-P by Ssu72 (Werner-Allen et al., 
2011; Xiang et al., 2010; Zhang et al., 2011).  ChIP experiments have shown that Ess1, 
much like Ssu72, is recruited mainly to the transcription terminator of RNAPII target 
genes and not to the gene body (Krishnamurthy et al., 2009).  Since the majority of S5-P 
is dephosphorylated during transcription elongation, these observations raise doubt the 
Ssu72 could be the only S5-P phosphatase (Figure 2). 
 
 
 
6 
	  
	  
 
Figure 2.  Model of RNAPII-dependent transcription in Saccharomyces cerevisiae.  The 
CTD of RNAPII exists in a hypophosphorylated state prior to forming a competent 
initiation complex at a gene promoter.  TFIIH increases S5-P and S7-P at the promoter 
following initiation, and as elongation proceeds, the phosphatases Rtr1 and Ssu72 
decrease S5-P as Bur1 and CTDK-1 phosphorylate S2.  As RNAPII approaches the 
terminator, Fcp1 removes S2-P, and Ssu72 attenuates S7-P to facilitate RNAPII 
recycling. 
 
Fcp1 has been experimentally shown to dephosphorylate S2-P (Cho et al., 2001; 
Kong et al., 2005), and Ssu72 has been shown to dephosphorylate both S5-P and S7-P 
(Krishnamurthy et al., 2004; Zhang et al., 2012).  However, neither phosphatase has been 
shown to regulate the transition from S5-P to S2-P during transcription elongation, where 
the largest drop in S5-P occurs.  Another protein, Rtr1 (regulator of transcription 1) was 
found to bind to phosphorylated RNAPII and was required for the induction of GAL 
genes by galactose (Gibney et al., 2008).  In 2009, using both in vitro and in vivo 
experiments, Mosley et al. demonstrated that Rtr1 is a CTD phosphatase that plays a 
crucial role in transcription elongation by regulating the transition of CTD S5-P to S2-P 
(Mosley et al., 2009).  Rtr1 was found to co-purify with a transcription competent form of 
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RNAPII with peak levels of Rtr1 localizing to active RNAPII target genes between the 
peaks of S5-P and S2-P RNAPII (Mosley et al., 2009).  In addition, rtr1Δ resulted in an 
accumulation of CTD S5-P in both whole cell extracts as well as across the open reading 
frames (ORFs) of two genes in yeast.  In vitro experiments revealed that Rtr1 is able to 
dephosphorylate the CTD alone or in the context of an elongation complex (containing 
DNA, RNA, and RNAPII) (Mosley et al., 2009).  Additionally, using both in vitro and in 
vivo methods, Egloff et al. recently identified that the human homolog of Rtr1 known as 
RPAP2 (RNAPII-associated polymerase 2) is a CTD phosphatase that dephosphorylates 
S5-P (Egloff et al., 2012).  The authors demonstrated that RPAP2 was recruited to 
RNAPII via S7-P, which resulted in the recruitment of Integrator and the 
dephosphorylation of S5-P at a representative RNAPII target snRNA gene in humans. 
The kinases and phosphatases that were introduced in this section and that have been 
shown to modify the RNAPII CTD during transcription are summarized in Table 1. 
 
 
 
 
 
 
 
 
 
  
8 
	  
	  
Table 1.  Kinases and phosphatases responsible for modifying the RNA polymerase II 
CTD during transcription.  The kinases responsible for phosphorylating the CTD are 
listed on the left side of the table and their opposing phosphatases are on the right. 
RNAPII CTD 
Kinases* 
Kinase 
Activity 
CTD Site Phosphatase 
Activity 
RNAPII CTD 
Phosphatases* 
TFIIK†    TFIIB 
(Kin28)¥ Cyclin 
dependent 
Ser-5/Ser-7 TFIIB 
associated 
(Ssu72)¥ 
(Ccl1) Kin28 cyclin    
(Tfb3)      
   Ser-5 Phosphatase Rtr1 
CTDK-I    TFIIF 
(Ctk1) Kinase Ser-2  (Tfg1) 
(Ctk2) Regulatory 
subunit 
  (Tfg2) 
(Ctk3)    (Taf14) 
BUR1-BUR2  Ser-2 Tfg1 associated (Fcp1) 
(Bur1) Cyclin 
dependent 
Ser-2   
(Bur2) Bur1 cyclin    
*Complex subunits or associated proteins are in parentheses 
†
TFIIK is a subcomplex of the general transcription factor TFIIH, which is comprised of Ssl2, Tfb1, Tfb2, 
and Ssl1subunits in addition to the TFIIK subunits 
¥
Dual CTD-serine specificity kinase/phosphatase 
 
III. The Recruitment of Rtr1 Phosphatase to RNAPII 
It was previously observed that RNAPII must exist in a hypophosphorylated state 
prior to forming a competent transcription initiation complex (Laybourn and Dahmus, 
1990; Lu et al., 1991).  Additionally, during transcription, specific kinases and 
phosphatases act on the CTD of RNAPII to regulate the phosphorylation state of S2, S5, 
and S7, which contributes to the regulation of RNAPII transcription as described.  
Specifically, the phosphatase Rtr1 was shown to regulate a key step important for 
transcription elongation and termination, likely through regulation of the transition of the 
phosphorylation state of the RNAPII-CTD from S5-P to S2-P during transcription 
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elongation (Mosley et al., 2009).  Although the role that Rtr1 plays in regulating the 
aforementioned transition has been described, the mechanism involved in the recruitment 
of Rtr1 to RNAPII has not been elucidated in yeast.  Consequently, the present work will 
focus on testing two key hypotheses.  The first of these was that Rtr1 is recruited to the 
RNAPII complex during transcription elongation through an interaction with an 
unidentified protein(s), and that post-translation modification of Rtr1 or its interacting 
partner(s) may also play a role in its recruitment to RNAPII.  Therefore, experiments 
were conducted to uncover protein-protein interactions and post-translational 
modifications involved in the recruitment of Rtr1 to RNAPII during transcription.  In 
2011, Fasolo et al. used protein arrays to demonstrate a direct interaction between two of 
the subunits of the CTDK-I complex (specifically Ctk1 and Ctk2) and Rtr1 (Fasolo et al., 
2011).  Therefore, the second hypothesis tested was that an interaction between Rtr1 and 
the CTDK-I complex is involved in the recruitment of Rtr1 to RNAPII.  Furthermore, it 
was hypothesized that Rtr1 is a substrate of Ctk1, the kinase subunit of CTDK-I, and that 
Rtr1 phosphorylation is also involved in its recruitment to RNAPII.  Alternatively, the 
requirement for CTDK-I may be associated with its kinase activity as a known modifier 
of S2 in the RNAPII CTD. 
The first objective of the present work was to identify novel proteins that interact with 
Rtr1 and RNAPII that could potentially facilitate its recruitment to RNAPII during 
transcription.  Specifically, we searched for proteins that interacted with Rtr1 alone, with 
RNAPII alone, and with the RNAPII-Rtr1 complex using affinity purifications followed 
by MudPIT analyses.  Special attention was given to interactions with the PAF complex, 
which is important in transcription initiation and elongation, as well as to post-
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translational modifications of the interacting partners, including RNAPII, which may play 
a role in recruiting Rtr1 to RNAPII. 
     The PAF complex is found in both yeast and higher eukaryotes, is comprised of five 
subunits (Paf1, Cdc73, Ctr9, Rtf1, and Leo1), and has been found to associate with 
RNAPII throughout the mRNA transcription cycle (Mueller and Jaehning, 2002; Mueller 
et al., 2004).  Furthermore, consistent with its presence at the promoter and continuing 
through transcription termination, PAF has been demonstrated to associate with an 
impressive list of transcription factors that are involved in regulating initiation and 
elongation, reviewed in (Jaehning, 2010), chromatin remodeling and modification 
(Gerber and Shilatifard, 2003), and mRNA export/processing (Mueller et al., 2004).  
Following its initial recruitment to RNAPII, PAF remains associated with RNAPII 
throughout transcription and may serve as a scaffold for the recruitment of transcription 
factors during elongation (Gerber and Shilatifard, 2003; Penheiter et al., 2005).  The 
interaction between Rtr1 and PAF subunits was previously observed (Mosley, A.L., 
unpublished data); therefore, we focused on confirming the interaction between the PAF 
complex and Rtr1 to determine if their interaction plays a role in Rtr1 recruitment. 
The second objective in understanding the mechanism involved in the recruitment of 
Rtr1 to RNAPII during transcription involved confirming the interaction between CTDK-
I and Rtr1 observed in vitro by Fasolo et al. in 2011.  CTDK-I plays an important role in 
regulating the activity of RNAPII through its phosphorylation of S2 and S5 of the CTD 
(Jones et al., 2004).  CTDK-I is comprised of catalytic (Ctk1) and regulatory (Ctk2) 
subunits, as well as a third subunit of unknown function (Ctk3) (Lee and Greenleaf, 
1989).  In 2004, Joes et al. reported the pattern of CTD phosphorylation by CTDK-I 
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(Jones et al., 2004); the authors used direct chemical analysis of in vitro experiments to 
determine that CTDK-I phosphorylates S5, that it phosphorylates S2 if S5 was previously 
phosphorylated, and that it shows increased affinity for CTD substrates that have been 
previously phosphorylated at either S2 or S5.   However, in vivo studies on CTDK-I 
mutants have shown that the kinase complex is responsible for the majority of the S2-P in 
yeast, whereas S5-P is not affected in vivo (Cho et al., 2001).  The focus of the present 
work in studying the role that CTDK-I may play in recruiting Rtr1 to RNAPII during 
transcription is two-fold.  First, the RNAPII-CTD phosphorylation pattern, for which 
CTDK-I plays a role, has been shown to recruit factors to RNAPII during transcription 
(Komarnitsky et al., 2000).  Additionally, studies on human RPAP2 have shown that it is 
capable of binding to a phosphorylated CTD at one site (S7-P) while targeting a different 
site for dephosphorylation (S5-P) (Egloff et al., 2012).  Second, a direct interaction 
between Rtr1 and two separate subunits of CTDK-I (specifically Ctk1 and Ctk2) was 
previously observed, although no biological role for this interaction was determined 
(Fasolo et al., 2011).  Additionally, the possibility that Rtr1 may serve as substrate for 
CTDK-I, and that the phosphorylation of Rtr1 by CTDK-I may play a role in the 
recruitment of Rtr1 to RNAPII, was investigated herein as well. 
In the present work, we studied the recruitment of Rtr1 to RNAPII in S. cerevisiae by 
investigating novel Rtr1-interacting proteins using affinity purification methods followed 
by MudPIT-LC/MS analysis.  The first set of experiments was conducted in yeast that 
expressed a TAP-tagged version of the RNAPII subunit, Rbp3, and C-terminally His-
FLAG-HA-tagged Rtr1 phosphatase (hence referred to as Rtr1-HFH).  This was followed 
by a single purification experiment in yeast that expressed C-terminally V5- or FLAG-
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tagged Rtr1.  The second research objective was pursued using single and double affinity 
purification steps to isolate CTDK-I subunits and Rtr1, which were subsequently detected 
by western blot.  Furthermore, the in vivo phosphorylation of Rtr1 by Ctk1 was 
investigated through the affinity purification of Rtr1-TAP from wild-type or CTDK-I 
mutant cells followed by MudPIT-LC/MS analysis. 
 
IV. The Development of Multi-Dimensional Protein Identification Technology 
The ability to identify global changes in gene expression has been feasible for more 
than a decade through the use of DNA microarrays to measure mRNA transcript levels 
(Boisvert et al., 2011; Lockhart and Winzeler, 2000).  However, complex mechanisms 
involved in mRNA translation, and differences in protein stability, can lead to a 
discrepancy between mRNA transcript levels and protein concentrations (Boisvert et al., 
2011).  This discrepancy uncovered the need to directly measure proteins in complex 
samples, which is a prerequisite to predict the effect of gene expression on biological 
function (Hatzimanikatis and Lee, 1999). 
Mass spectrometry (MS) is the method of choice for identifying and quantifying 
proteins in complex samples such as cell lysates.  In order to generate molecules with 
better mass spectrometric properties, the intact proteins in a sample are typically digested 
with a protease such as trypsin.  This step, although necessary, serves to further increase 
the complexity of the sample.  Therefore, prior to proteolytic digestion and mass 
spectrometric analysis, the intact proteins in a sample must be resolved from each other.   
Historically, two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) was 
the approach most widely used to achieve protein resolution (Hanash, 2000).  Using this 
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approach, proteins are separated in the first dimension by their isoelectric point (pI) using 
isoelectric focusing (IEF) followed by a second dimension of separation by molecular 
weight using SDS-PAGE (Friedman et al., 2009).  Following separation, each protein 
spot must be excised and extracted from the SDS-PAGE gel preceding proteolytic 
digestion and MS analysis.  Major shortcomings to this approach include that it is 
tedious, time-consuming, and is insufficient for low abundance proteins, membrane 
bound proteins, or proteins with extreme pI values or molecular weight, reviewed in 
(Coombs, 2011). 
The need to improve the throughput of direct protein analyses, as well as to measure 
low abundance proteins and those that cannot easily be resolved by 2D gels provided an 
impetus for the development of multidimensional liquid chromatographic approaches.  In 
1999, Link et al. reported their strategy for the direct analysis of large protein complexes 
(DALPC) that they implemented to identify individual proteins in large complexes within 
a cell (Link et al., 1999).  Unlike 2D-PAGE, their approach could be placed online with a 
mass spectrometer, which greatly improved the efficiency of protein measurements.  
Following denaturation and proteolytic digestion of the proteins in a sample, the DALPC 
process separates the resulting complex mixture of proteolytic peptides using two-
dimensional liquid chromatography.  Peptides are separated in the first dimension by 
their isoelectric point using strong cation exchange (SCX), eluted from SCX using 
increasing concentrations of KCl, and further separated in the second dimension by their 
hydrophobicity using reverse phase (RP) chromatography.  The chromatographically 
resolved peptides exit the RP directly into the tandem mass spectrometer for analysis.  
Following analysis, the resulting MS/MS spectra are submitted to a protein search 
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algorithm such as SEQUEST that correlates them with theoretical spectra generated from 
the protein sequences in a species-specific FASTA database (MacCoss et al., 2002; 
Moore et al., 2001).  This process was subsequently adapted for the rapid analysis of 
large-scale proteomes, such as Saccharomyces cerevisiae, and was termed 
multidimensional protein identification technology (MudPIT) (Washburn et al., 2001).  A 
major difference between MudPIT and DALPC is the use of ammonium acetate as the 
salt for elution of the peptides from SCX (Link et al., 1999; Washburn et al., 2001).  
MudPIT-LC/MS has been demonstrated to be highly reproducible for quantitatively 
measuring proteins complex components in S. cerevisiae as well as peptide mapping of 
post-translational modification (Black et al., 2008; Litovchick et al., 2011; McDonald and 
Yates, 2002; Mosley et al., 2011).  Consequently, MudPIT-LC/MS was utilized as the 
primary analytical tool for the work presented here. 
 
V. Introduction to Tandem Affinity Purification 
The recent sequencing of the complete genomes of several species has provided the 
means to delve deeper into the biochemistry of these biological systems.  The availability 
of genomic information facilitates determining the identity of encoded proteins using 
methods such as mass spectrometry.  Additionally, using techniques such as mass 
spectrometry, the direct measurement of protein post-translational modifications, protein-
protein interactions, and protein expression level is achievable.  
Historically, studying protein-protein interactions at the level of an organism was 
accomplished by two-hybrid screening, reviewed in (Petschnigg et al., 2011).  However, 
issues with selectivity and the need for orthogonal strategies to complement two-hybrid 
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experiments has led to the combination of protein purification schemes and mass 
spectrometry, which has allowed the rapid identification of interacting partners (Puig et 
al., 2001).  Because of the wide range of physicochemical properties that can be taken 
advantage of to isolate a target protein, it is exceedingly difficult to develop a generic 
protein purification scheme.  To address this shortcoming, Puig et al. published their 
Tandem Affinity Purification (TAP) method in 2001, which they targeted to the 
purification of native protein complexes (Puig et al., 2001).  One shortcoming of Puig’s 
methodology is difficulty in purifying insoluble membrane and chromatin-bound 
proteins; however, affinity-purification schemes have subsequently been utilized to study 
chromatin-associated (Lambert et al., 2009; Mosley et al., 2009) and membrane-bound 
proteins (Wisniewski, 2011). 
The TAP method for the purification of protein complexes (Rigaut et al., 1999) 
involves the fusion of a TAP tag to the N- or C-terminus of the target protein.  In yeast, 
this can be accomplished with standard molecular biology techniques and polymerase 
chain reaction (Knop et al., 1999); homologous recombination is efficient in yeast and 
can be used to introduce the TAP tag to the protein of interest through the direct 
incorporation of the C-terminal TAP tag sequence into the chromosomal locus of the 
protein-encoding gene of interest.  The work presented here relies on the use of the C-
terminal TAP tag, which incorporates two different epitopes that can be taken advantage 
of for purification (see Table 2).  These include the ZZ binding domains of Protein A 
(Staphylococcus aureus), which bind strongly to the fragment crystallizable region (Fc) 
of IgG, and calmodulin binding peptide (CBP) (Chang, 2006).  The two binding regions 
are separated by a Tobacco Etch Virus (TEV) protease cleavage site, which is used to 
16 
	  
	  
facilitate cleavage of the fusion protein N-terminal to the Protein A portion of the epitope 
tag resulting in elution of the protein of interest from the IgG resin.  Following 
preparation of the yeast cell extract, the protein of interest and its interacting partners are 
isolated using a two-step purification process, which relies on the Protein A and CBP 
portions of the TAP tag.  The resulting proteins are highly purified and are subjected to 
tandem MS analysis. 
In addition to the TAP tag, other affinity tags can be used individually or in 
combination to study the interaction of proteins of interest and identify new interacting 
partners that may be required for their recruitment or function.  The use of different 
protein tag combinations for tandem affinity purification was reviewed by Li in 2010 (Li, 
2010), and a list of the tags used in the present work is presented in Table 2.  It should 
also be mentioned that the methods presented here can be applied to mammalian system, 
and Burckstummer et al. presented their method of TAP purification to study interaction 
proteomics in mammalian cells (Burckstummer et al., 2006). 
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Table 2. Affinity tags used in the purification of Rtr1, RNAPII, CTDK-I, and their 
interacting partners.  The table includes the tag epitopes and the reagents used to 
capture/elute them during the purification process. 
Tag Epitope Affinity to Elution 
FLAG DYKDDDDK FLAG antibody-
conjugated agarose 
resin 
FLAG peptide, 
acid, on-resin 
digestion (trypsin) 
6XHIS HHHHHH Ni(2+), Co(2+) Imidazole 
CBP KRRWKKNFIAVSA-
ANRFKKISSSGAL 
Target of 
Calmodulin resin 
(+Ca dependent) 
EGTA 
V5 GKPIPNPLLGLDST V5 antibody-
conjugated agarose 
resin 
V5 peptide, acid 
Protein A Staphylococcus 
aureus IgG-binding 
domains 
IgG-conjugated 
sepharose resin 
DTT, surfactant; 
TEV protease 
(when part of TAP 
tag) 
HA YPYDVPDYA HA antibody-
conjugated agarose 
resin 
HA peptide, acid 
HFH* 6XHis-3XFLAG-
TEV-3XHA 
See 6XHIS, FLAG, 
HA 
See 6XHIS, FLAG, 
HA 
TAP* CBP-TEV-Protein A See CBP, Protein A See CBP, Protein A 
*The HFH and TAP tags are prepared from combinations of the other listed tag formats. 
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MATERIALS AND METHODS 
 
I. Materials and Reagents 
Table 3.  Materials and reagents used in the investigation of protein-protein interactions 
with Rtr1 phosphatase 
Reagent Source / Preparation 
5% SDS-PAGE Stacking Gel 1.25 mL polyacrylamide (40%), 1.25 mL tris-
HCl (1 M, pH 6.8), 0.1 mL ammonium 
persulfate (10%), 0.1 mL SDS (10%), 0.01 mL 
TEMED, 7.3 mL ddH2O 
10% SDS-PAGE Gel 7.5 mL polyacrylamide (40%), 7.5 mL Tris-
HCl (1 M, pH 6.8), 0.3 mL ammonium 
persulfate (10%), 0.3 mL SDS (10%), 0.012 mL 
TEMED, 14.4 mL ddH2O 
12% SDS-PAGE Gel 8 mL polyacrylamide (40%), 7.5 mL Tris-HCl 
(1 M, pH 8.8), 0.2 mL ammonium persulfate 
(10%), 0.2 mL SDS (10%), 0.008 mL TEMED, 
4.1 mL ddH2O 
AcTEV Protease Invitrogen, catalog # 12575-023; 10,000 
units/µL 
Agar Thermo Fisher catalog # BP1423-500 
Anti-Calmodulin Binding 
Protein Antibody (α-CBP) 
Thermo Fisher catalog # CAB1001, 0.5 mg/mL 
Anti-FLAG-HRP Antibody Sigma catalog # A8592-1MG 
Anti-FLAG Resin Sigma catalog # A2220-5ML, M2-Agarose 
Anti-Rabbit IgG-HRP GE Healthcare catalog # NA934V 
Anti-V5 Agarose Sigma catalog # A7345-1ML 
Anti-V5 Antibody/Horse Radish 
Peroxidase (α-V5-HRP) 
Invitrogen catalog # R96125 
Blocking Buffer 5% Milk in Tris Buffered Saline 
Bio-Rad Precision Plus Protein 
Standards 
Bio-Rad catalog # 161-0374 
Calmodulin Binding Buffer 10 mM Tris (pH 8), 1 mM magnesium acetate, 
1 mM imidazole, 2 mM calcium chloride, 10% 
glycerol, 0.5 mM DTT, 1X yeast protease 
inhibitors 
Calmodulin Elution Buffer 10 mM Tris (pH 8), 0.3 M sodium chloride, 1 
mM magnesium acetate, 1 mM imidazole, 2 
mM EGTA, 10% glycerol, 0.5 mM DTT, 1X 
yeast protease inhibitors 
Calmodulin-sepharose resin GE Healthcare catalog # 17-0529-01 
Chloroacetamide (CAM) Sigma catalog # 22790 
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Reagent Source / Preparation 
Developing Solution 2.5% sodium carbonate, 0.05% formaldehyde, 
0.005% sodium thiosulfate in ddH2O (w/v) 
Digestion Buffer 95:5 ammonium bicarbonate (50 mM, pH 
8.5)/methanol (v/v) 
DNAse I Sigma catalog # D4623 
ECL Plus Reagent GE Healthcare catalog # RPN2133, reagent A 
and B were mixed in a 40:1 ratio, respectively 
EconoPrep Column Bio-Rad catalog # 731-1550 
Endoproteinase Lys-C Promega catalog # V1071 
Ethanol Wash 30:70 ethanol/ddH2O (v/v) 
Fixing Solution 30:10:60 ethanol/acetic acid/ddH2O (v/v/v) 
Heparin Sigma catalog # H3393 
IgG-Sepharose Resin GE Healthcare catalog # 17-0969-01 
Immun-Star WesternC Kit Bio-Rad catalog # 170-5070 
Laemmli Buffer Bio-Rad catalog # 161-0737 
Mini-ProteanTGX Any KD 
Protein Gel 
Bio-Rad catalog # 456-9034 
Peptone BD catalog # 211820-2KG 
Precision Plus Ladder Bio-Rad catalog # 161-0374 
Precision Plus Protein Dual Xtra 
Standards (protein ladder) 
Bio-Rad catalog # 161-0377 
Protease Inhibitor Cocktail 10,000X, Sigma catalog # P8215-5ML 
Salmon Sperm DNA Sigma catalog # D7656-1ML 
Sensitizer Solution 0.02% sodium thiosulfate in ddH2O (w/v) 
Silver Nitrate Solution 0.1% silver nitrate, 0.02% formaldehyde in 
ddH2O (w/v) 
Stop Solution 0.5% glycine in ddH2O (w/v) 
TAP Lysis Buffer 40 mM hepes (pH 7.5), 10% glycerol, 350 mM 
NaCl, 0.1% tween-20, 0.5 mM DTT, 1X yeast 
protease inhibitors 
TCEP 0.1 M, Pierce catalog # 77720 
TEV Cleavage Buffer 10 mM tris (pH 8), 150 mM NaCl, 0.1% 
IGEPAL, 0.5 mM EDTA, 10% glycerol, 1 mM 
DTT, 1X yeast protease inhibitors 
Transfer Buffer 5.8 g tris-HCl, 2.9 g glycine, 900 mL ddH2O, 
100 mL methanol, 3.75 µL SDS (10%) 
Tris/Gly/SDS Run Buffer Bio-Rad catalog # 161-0732 
Tris Buffered Saline (TBS) Sigma catalog # T5912 
Tris-HCl Buffer 100 mM Tris-HCl in ddH2O (pH 8.5) 
Trypsin Gold Promega catalog # V-5280, 100 µg/mL 
following reconstitution with 50 mM acetic acid  
Yeast Extract Sigma catalog # Y1625-1KG 
Yeast Protease Inhibitors 10,000X, Sigma catalog # P8215 
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Reagent Source / Preparation 
YPD Media 30 g yeast extract, 60 g peptone, 2.7 L distilled 
water, 300 mL of 20% dextrose (w/v); sterilize 
by autoclaving 
 
II. Rpb3-TAP/Rtr1-HFH Purification Scheme 
Yeast Cell Lysis 
Yeast cells that express RNAPII with a TAP-tagged version of the Rpb3 subunit 
(Rpb3-TAP), and Rtr1 containing an HFH tag (Rtr1-HFH), were cultured in YPD media 
at 30 ºC and grown to an OD600 ~2.  The cells were centrifuged, and the supernatant was 
removed, and the cells were washed with ddH2O.  Following centrifugation to remove 
the cell wash, the cells were re-suspended in Tap Lysis Buffer (10:1 Lysis Buffer/Cells, 
v/v), which was subsequently transferred to a liquid nitrogen bath using a syringe with an 
18-gauge hypodermic needle.  The frozen cell pellet was pulverized with a mortar and 
pestle, and two parts cell pellet and one part powdered dry ice were transferred into a 
Waring blender for further homogenization.  The frozen homogenate was transferred to a 
second vessel and was allowed to thaw in a water bath at ambient temperature.  The cell 
homogenate was treated with DNase I (100 units) and heparin (300 µg) for 10 min 
(ambient temperature) and was clarified by centrifugation as previously described 
(Mosley et al., 2009; Mosley et al., 2011).  Following centrifugation, the clarified 
supernatant was transferred to a clean beaker to be used for affinity purification. 
Purification of Proteins that Interact with Rtr1-HFH 
The first step of the purification targeted proteins that interact with Rtr1-HFH when it 
was not in complex with RNAPII (Figure 3).  In this experiment, the supernatant from the 
yeast whole cell lysate was treated with 500 µL of IgG-sepharose to immunoprecipitate 
the RNAPII complex via the Protein A portion of the Rpb3-TAP subunit.  Following 
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incubation on a stir plate at 4 ºC, the IgG-sepharose was separated from the yeast cell 
lysate supernatant by gravity flow through a 30 mL Bio-Rad Econoprep column.  The 
IgG-sepharose resin was washed with 30 mL of TAP Lysis Buffer, and the column flow-
through containing unbound Rtr1-HFH that was not associated was transferred to a clean 
beaker.  To isolate Rtr1-HFH and any interacting proteins, the Bio-Rad column flow-
through was further treated with 100 µL of anti-FLAG resin and incubated with stirring 
overnight at 4 ºC.  Following incubation, the sample was transferred to a second 
Econoprep column, and the supernatant was allowed to drain through the column by 
gravity flow.  The column containing the anti-FLAG resin was washed with 30 mL of 
TAP Lysis Buffer followed by 1 mL of 50 mM ammonium bicarbonate (pH 8.5) to 
remove any proteins that did not interact with Rtr1.  The anti-FLAG resin was re-
suspended with 500 µL of Digestion Buffer and 10 µL of 100 µg/mL Trypsin Gold.  The 
re-suspended sample was transferred to a 1.5 mL centrifuge tube and was digested “on-
resin” overnight (with mixing) at 37 ºC.  The following day, the sample wash centrifuged 
to remove the anti-FLAG resin, and the supernatant was acidified with 10 µL of formic 
acid and was loaded to a MudPIT column for LC/MS analysis. 
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Figure 3.  Purification scheme used to identify Rtr1-interacting proteins not in complex 
with RNAPII.  In step 1, RNAPII is immunoprecipitated from yeast cell lysate with IgG-
sepharose resin.  The proteins that were not removed by the IgG-sepharose (step 2) and 
that interact with Rtr1-HFH were immunoprecipitated with anti-FLAG resin (step 3).  
Following “on-resin: digest with trypsin, the resulting peptides were analyzed by 
MudPIT-LC/MS (step 4). 
 
Purification of Proteins that Interact with RNAPII 
The second step of the purification targeted proteins that interact with RNAPII when 
it was not in complex with Rtr1-HFH (Figure 4).  In this experiment, the supernatant 
from the yeast whole cell lysis was treated with 500 µL of IgG-sepharose to 
immunoprecipitate the RNAPII complex via the Protein A portion of the Rpb3-TAP 
subunit.  Following incubation on a stir plate at 4 ºC, the IgG-sepharose was separated 
from the yeast cell lysate supernatant with a 30 mL Bio-Rad Econoprep column.  The 
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IgG-sepharose resin was washed with 30 mL of TAP Lysis Buffer and 3 mL of TEV 
Cleavage Buffer to remove non-interacting proteins.  Next, the washed IgG-sepharose 
resin containing immunoprecipitated RNAPII was re-suspended with 1 mL of TEV 
Cleavage Buffer and transferred to a 1.5 mL centrifuge tube.  The sample was treated 
with 10 µL of AcTEV protease to elute RNAPII and its interacting partners from the IgG-
sepharose resin (incubated overnight at 4 ºC with agitation). 
The following day, the sample was transferred to a 30 mL Econoprep column and 
was allowed to drain into a 500 mL beaker by gravity flow.  The column was 
subsequently washed with 30 mL of TAP Lysis Buffer, and the column flow-through 
(including the wash) was treated with 100 µL of anti-FLAG resin to remove any Rtr1 that 
was associated with RNAPII (incubated with stirring overnight at 4 ºC).  
Following incubation, the sample was transferred to a second Econoprep column, and 
the eluate was allowed to drain through the column by gravity flow.  The column 
containing the anti-FLAG resin was washed with 15 mL of Calmodulin Binding Buffer to 
remove RNAPII and interacting proteins that did not interact with Rtr1.  The column 
flow-through was collected in a 15 mL centrifuge tube.  Following the addition of 3 µL 
of 1 M calcium chloride to facilitate the CBP-calmodulin interaction, 200 µL of 
calmodulin-sepharose resin (pre-washed with Calmodulin Binding Buffer) was added to 
the sample to immunoprecipitate RNAPII and interacting proteins via the calmodulin-
binding portion of the Rpb3-TAP tag.  The sample was incubated overnight at 4 ºC on a 
rotating wheel. 
The resin containing immunoprecipitated RNAPII and interacting proteins was 
transferred to a 20 mL Econoprep column to drain by gravity flow, and the remaining 
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resin wash washed with 30 mL of Calmodulin binding Buffer.  Next, RNAPII and 
interacting proteins were eluted from the calmodulin resin with five 1 mL aliquots of 
Calmodulin Elution Buffer containing EGTA to chelate the calcium chloride; the 
individual elutions, numbered E1-E5, were collected in 1.5 mL centrifuge tubes.  (Each 
elution was incubated at ambient temperature for five minutes prior to be collected by 
gravity flow.) 
The individual calmodulin elutions (E1-E5) were analyzed by SDS-PAGE with silver 
staining by first preparing a 10% SDS-PAGE gel with a 5% stacking gel.  Aliquots (8 
µL) of 4X Loading Dye were added to 24 µL aliquots of each of the calmodulin elutions, 
and the samples were denatured at 100 ºC for 5 min.  Following denaturation, the entire 
volume of each aliquot was loaded to the SDS-PAGE gel along with 2.5 µL of a 1:10 
dilution of the Precision Plus Protein Standards.  The gel was run in Tris/Gly/SDS buffer 
at 180 V for 50 min.  Following PAGE, the lanes and stacker was cutoff the SDS-PAGE 
gel, and the gel was placed in 100 mL of Fixing Solution overnight at ambient 
temperature.  The following day, the Fixing Solution was discarded, and 100 mL of 
Ethanol Wash were added; the gel was incubated at room temperature for 10 min.  This 
procedure (discarding the previous wash, adding the next wash, and incubating at 
ambient temperature for 10 min) was repeated for a water wash, the Sensitizer Solution, a 
water wash, Silver Nitrate Solution, a water wash, the Developing Solution, respectively.  
Following addition of the developing solution, the progress of the silver staining was 
monitored until the proper level of staining was achieved (2-10 min), and washing the gel 
with Stop Solution for 10 min at ambient temperature quenched the development.  The 
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Stop Solution was removed, the gel was rinsed with ddH2O, and the gel was imaged with 
a flatbed digital scanner. 
Prior to LC/MS analysis, calmodulin elution E2 was prepared using a trichloroacetic 
acid (TCA) precipitation protocol preceding proteolytic digestion.  Briefly, 100 µL of 
sample E2 was transferred to a 1.5 mL centrifuge tube, and 200 µL of 4 ºC Tris-HCl were 
added to the sample.  Next, 100 µL of 100% TCA were added to the sample followed by 
vortex mixing; the sample was incubated overnight at 4 ºC.  The following day, the 
sample was centrifuged for 30 min at 14,000 RPM and 4 ºC (full speed), and the 
supernatant was discarded.  Acetone (500 µL at 4 ºC) was added to the pellet followed by 
vortex mixing, and the sample was centrifuged for 10 min at full speed.  The sample was 
washed with acetone a second time as previously described, the acetone was removed, 
and the tube was uncapped until the remaining acetone had evaporated.  The sample was 
reconstituted with 30 µL of 8 M urea in Tris-HCl, and 1.5 µL of TCEP (5 mM final 
concentration) were added; the sample was incubated at ambient temperature for 30 min.  
Following sample reduction, the sample was alkylated by the addition of 0.6 µL of CAM 
(final concentration 10 mM); the sample was incubated in the dark for 30 min.  Next, the 
sample was digested with 0.3 µL of endoproteinase Lys-C overnight at 37 ºC.  The 
following day, the urea was diluted by the addition of 90 µL of Tris-HCL and 0.6 µL of 
calcium chloride (final concentration 2 mM), and the sample was digested with Trypsin 
Gold (0.5 µg) overnight at 37 ºC preceding analysis by MudPIT-LC/MS. 
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Figure 4.  Purification scheme used to identify RNAPII-interacting proteins not in 
complex with Rtr1.  In step 1, RNAPII is immunoprecipitated from yeast cell lysate with 
IgG-sepharose resin, unassociated proteins are washed away, and RNAPII was eluted 
from IgG-sepharose with AcTEV protease (step 2).  In step 3, Rtr1-HFH and associated 
proteins were removed through immunoprecipitation with anti-FLAG resin, and the 
remaining RNAPII and associated proteins were immunoprecipitated with calmodulin 
resin (step 4).  In step 5, RNAPII and associated proteins are eluted from calmodulin 
resin with EGTA and analyzed by SDS-PAGE and MudPIT-LC/MS.  
 
Purification of Proteins that Interact with the RNAPII-Rtr1 Complex 
The third step of the purification targeted proteins that interact with the Rtr1-RNAPII 
complex (Figure 5).  The yeast cell lysate was prepared in the same manner as was 
presented in the above section, “Purification of Proteins that Interact with RNAPII,” 
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including the immunoprecipitation with IgG-sepharose, the elution of RNAPII and 
interacting proteins from IgG-sepharose with AcTEV protease, and the 
immunoprecipitation of proteins in the IgG-sepharose eluate with anti-FLAG resin.  
However, at this point in the purification, the two procedures diverged.  On the day 
following the immunoprecipitation of the protein that interacted with the Rtr1-RNAPII 
complex, The EconoPrep column containing the anti-FLAG resin was washed with 30 
mL of TAP Lysis Buffer, which was allowed to drain by gravity flow into a 500 mL 
beaker.  The anti-FLAG resin collected in the column was subsequently washed with 1 
mL of 50 mM ammonium bicarbonate, and the resin was re-suspended with 500 µL of 
Digestion Buffer.  The re-suspended resin was transferred to a clean, 1.5 mL centrifuge 
tube, the sample was centrifuged, and 300 µL of the supernatant was removed and 
discarded.  An aliquot of Trypsin Gold (10 µL of 100 µg/mL) was added to the remaining 
supernatant/anti-FLAG resin, and the sample was digested “on-bead” overnight at 37 ºC.  
Following incubation, the sample was centrifuged, and the supernatant containing the 
digested proteins was transferred to a clean 1.5 mL centrifuge tube prior and stored at -80 
ºC prior to MudPIT-LC/MS analysis. 
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Figure 5.  Purification scheme used to identify proteins that interact with the RNAPII-
Rtr1 complex.  In step 1, RNAPII is immunoprecipitated from yeast cell lysate with IgG-
sepharose resin, unassociated proteins are washed away, and RNAPII is eluted from IgG-
sepharose with AcTEV protease (step 2).  In step 3, Rtr1-HFH and associated proteins are 
removed with anti-FLAG resin.  In step 4, RNAPII, Rtr1, and associated proteins are 
eluted from anti-FLAG resin with FLAG peptide, and analyzed by MudPIT-LC/MS 
following digestion with trypsin. 
 
III. Rtr1-1XFLAG Purification Scheme 
Yeast Cell Lysis 
Yeast cells that express a 1X-FLAG tagged version of the phosphatase Rtr1 (Rrt1-
1XFLAG) were cultured in YPD media at 30 ºC to an OD600 of ~4.  The cells were 
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centrifuged, the supernatant was removed, and the cells were washed with ddH2O.  
Following centrifugation to remove the cell wash, the cells were re-suspended in TAP 
Lysis Buffer and were processed in the same fashion as was described in Section II above 
(Rpb3-TAP/Rtr1-HFH Purification Scheme, Yeast Cell Lysis). 
Purification of Proteins that Interact with Rtr1-1XFLAG 
This purification scheme targeted proteins that interact with Rtr1-1XFLAG (Figure 
6).  In this experiment, an aliquot (200 µL) of anti-FLAG resin was washed with 1 mL of 
TAP Lysis Buffer and was added to the supernatant from the yeast cell lysate.  The 
sample was incubated for approximately 24 hours at 4 ºC with stirring, and the anti-
FLAG resin containing Rtr1-1XFLAG and any interacting proteins was recovered by 
passing the sample over a 30 mL EconoPrep column.  The sample was allowed to drain 
into a 500 mL beaker by gravity, and the anti-FLAG resin remaining in the column was 
washed with 30 mL of TAP Lysis Buffer followed by 1 mL of 50 mM ammonium 
bicarbonate (pH 8.5) to remove any proteins that did not interact with Rtr1.  The anti-
FLAG resin was re-suspended with 500 µL of Digest Buffer and 10 µL of 100 µg/mL 
Trypsin Gold.  The re-suspended sample was transferred to a 1.5 mL centrifuge tube and 
was digested “on-resin” overnight (with mixing) at 37 ºC.  The following day, the sample 
was centrifuged to remove the anti-FLAG resin, and the supernatant was acidified with 
10 µL of formic acid and was loaded to a MudPIT column for LC/MS analysis. 
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Figure 6.  Purification scheme used to identify proteins that interact with Rtr1.  In step 1, 
Rtr1-1XFLAG is immunoprecipitated with anti-FLAG resin, unassociated proteins are 
washed away, and Rtr1 and associated proteins are eluted from anti-FLAG resin with 
FLAG peptide (step 2).  In step 3: the eluted proteins are precipitated with TCA, digested 
with trypsin, and analyzed by MudPIT-LC/MS. 
 
IV. CTDK1-TAP/Rtr1-V5 Purification Scheme 
Yeast Cell Lysis 
Two different yeast strains that express a TAP-tagged version of either of the CTDK-
I subunits Ctk1 or Ctk2, and a V5-tagged version of Rtr1 were cultured in YPD media at 
30 ºC to an OD600 of approximately four.  The cells were centrifuged, the supernatant was 
removed, and the cells were washed with ddH2O.  Following centrifugation to remove 
the cell wash, the cells were re-suspended in TAP Lysis Buffer and were processed in the 
same fashion as was described in Section II above (Rpb3-TAP/Rtr1-HFH Purification 
Scheme, Yeast Cell Lysis). 
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CTDK-I and Rtr1 Single Purification Scheme 
The objective of this purification scheme was to confirm the in vivo interaction 
between Rtr1-V5 and CTDK-I (via Ctk1-TAP or Ctk2-TAP), see Figure 7.  The present 
experiment utilized a single purification step in which an aliquot (200 µL) of pre-washed 
IgG-sepharose resin was added to the supernatant from the yeast cell lysates (Ctk1-
TAP/Rtr1-V5 or Ctk2-TAP/Rtr1-V5 strains); separate 100 µL aliquots of the yeast 
lysates were set aside to serve as the input controls.  The samples were incubated for 
approximately 24 hours at 4 ºC with stirring, and the IgG-sepharose resin containing 
Ctk1/2-TAP and Rtr1-V5, if present, was recovered by passing the samples over 30 mL 
EconoPrep columns.  The samples were allowed to drain into 500 mL beakers by gravity 
flow, and the IgG-sepharose resin remaining on the columns was washed with 30 mL of 
TAP Lysis Buffer to remove any non-interacting proteins.  The IgG-sepharose resin from 
each sample was re-suspended with 200 µL of TAP Lysis Buffer, transferred to clean 
microcentrifuge tubes, and stored at -80 ºC. 
IgG-sepharose treated and input control samples were removed from the freezer and 
were allowed to thaw in a water bath at ambient temperature.  An aliquot of 4X Loading 
Dye was added to the samples, which we subsequently boiled for 10 min to elute the 
proteins from the resin.  The samples were centrifuged at 14,000 RPM at 4 ºC for 10 min, 
and the supernatants were transferred to clean microcentrifuge tubes.  The input control 
samples (10 µL) and the experimental samples (30 µL, Ctk1-TAP/Rtr1-V5 and Ctk2-
TAP/Rtr1-V5) were loaded in duplicate to a 12% SDS-PAGE gel, which was run in 
Tris/Gly/SDS Run Buffer at 200 V for 50 min.  Following the SDS-PAGE analysis, the 
gel was blotted to nitrocellulose overnight at 30 V in Transfer Buffer. 
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Following the Western transfer, the nitrocellulose membrane was placed in Blocking 
Buffer for approximately 2 hours and cut in half; each of the halves contained a full 
complement of samples: Ctk1-TAP/Rtr1-V5 input and experimental samples, and Ctk2-
TAP/Rtr1-V5 input and experimental samples.  The left half of the nitrocellulose 
membrane was probed by incubating it overnight at 4 ºC in 1:1000 diluted (in Block 
Buffer) anti-calmodulin binding protein antibody (α-CBP).  Likewise, the right half of the 
membrane was probed with 1:1000 diluted anti-V5 antibody directly conjugated to 
horseradish peroxidase (α-V5-HRP).  The next day, the membranes were removed from 
the primary antibody solutions.  The sample probed with α-V5-HRP was washed three 
times with TBS (10 min per wash) and developed with ECL Plus reagent.  The sample 
probed with α-CBP was washed three times with TBS (10 min per wash) and was placed 
in 1:1000 diluted (in Block Buffer) secondary antibody (anti-rabbit IgG-HRP) for two 
hours at ambient temperature.  Following incubation, the membrane was removed from 
the secondary antibody solution, washed as above, and developed with ECL Plus reagent.  
Both membranes were imaged using a Fuji Scanner (FLA 5000) at 473 nm using the LPB 
filter setting. 
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Figure 7. Rtr1-V5/CTDK-I-TAP single and double purification schemes are shown.  In 
the single purification scheme, CTDK-I and associated proteins are immunoprecipitated 
from yeast cell lysate via the Ctk1-TAP (or Ctk2-TAP) subunit using IgG-sepharose.  
CTDK-I and associated proteins are eluted from IgG-sepharose using TEV protease (step 
1), and CTDK-I and Rtr1 are detected by Western blot.  In the double purification 
scheme CTDK-I and Rtr1 (if present) are immunoprecipitated via the Rtr1-V5 tag (using 
anti-V5 resin) prior to detection by Western blot. 
 
CTDK-I and Rtr1 Double Purification Scheme 
The objective of this purification scheme was to confirm the in vivo interaction 
between Rtr1-V5 and CTDK-I (via Ctk1-TAP or Ctk2-TAP), see Figure 7.  The present 
experiment utilized a two purification steps.  In the first step, an aliquot (250 µL) of pre-
washed IgG-sepharose was added to the supernatant from the yeast cell lysates (Ctk1-
TAP/Rtr1-V5 or Ctk2-TAP/Rtr1-V5 strains); separate 100 µL aliquots of the yeast 
lysates were set aside to serve as the input controls.  The samples were incubated for 
approximately 24 hours at 4 ºC with stirring, and the IgG-sepharose resin containing 
Ctk1/2-TAP and Rtr1-V5, if present, was recovered by passing the samples over 30 mL 
EconoPrep columns.  The samples were allowed to drain into 500 mL beakers by gravity 
flow, and the IgG-sepharose resin remaining on the columns was washed with 30 mL of 
TAP Lysis Buffer to remove any non-interacting proteins.  Next, the IgG-sepharose was 
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washed a second time with 3 mL of TEV Cleavage Buffer, was re-suspended with 1 mL 
of TEV Cleavage Buffer, and was transferred to clean microcentrifuge tubes.  
Afterwards, CTDK-I and Rtr1 (if present) were eluted from the IgG-sepharose resin 
following the addition of 10 µL of AcTEV protease, which was incubated overnight at 4 
ºC.  The following day, the samples were passed through a 10 mL EconoPrep column, 
and the flow-through was collected into a 15 mL centrifuge tube.  The column was 
washed with 9 mL of TAP Lysis Buffer, which was added to the same tubes.  The eluted 
proteins were incubated with 100 µL of pre-washed anti-V5 agarose overnight at 4 ºC on 
a rotating wheel. 
The next day, the anti-V5 agarose containing Rtr1-V5 and CTDK-I, if present, was 
recovered by passing the samples over 30 mL EconoPrep columns.  The samples were 
allowed to drain into 500 mL beakers by gravity flow, and the agarose resin remaining on 
the columns was washed with 30 mL of TAP Lysis Buffer to remove any non-interacting 
proteins.  Next, the resin from each sample was re-suspended with 200 µL of TAP Lysis 
Buffer, transferred to clean microcentrifuge tubes, and stored at -80 ºC.  On the day of 
analysis, the samples were analyzed by Western blot in the same fashion as was 
described in the above section (Purification of CTDK-I and Rtr1, Single Purification). 
 
V. MudPIT-LC/MS Analysis 
Samples were prepared for MudPIT-LC/MS analysis either by TCA precipitation or 
by direct digestion with trypsin as described in the individual protein purification sections 
above.  Following digestion with trypsin, the samples were quenched by the addition of 
1% formic acid prior to being loaded on a two dimensional MudPIT capillary column as 
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previously described (Florens and Washburn, 2006).  Each of the samples from the 
aforementioned protein purifications was subjected to a 10-step MudPIT analysis as 
previously described with specific updates and modifications as indicated below (Wolters 
et al., 2001).  Following each of the 10 steps, the chromatographically resolved peptides 
were eluted into a ThermoFisher LTQ Velos for mass spectrometric (MS) analysis; the 
LC/MS system was equipped with a Proxeon nano-liquid chromatograph and an in-house 
modified nano-electrospray source designed specifically for MudPIT-LC/MS.  Following 
MS analysis, the tandem mass spectra were submitted to the SEQUEST algorithm for 
protein identification using Proteome Discoverer software (Thermo).  Spectra were 
search against a FASTA database containing 5819 Saccharomyces cerevisiae protein 
sequences (downloaded from NCBI build from 04/26/11) and 281 common contaminant 
proteins including human keratins, immunoglobins, and proteolytic enzymes.  Reversed 
versions of all non-redundant peptides were included in the database as a means of 
estimating false discovery rates (FDR). FDRs were kept at 2% or lower for all the data 
analysis performed in this work.  To account for reduction and carbamidomethylation 
(alkylation, CAM) of cysteine-containing peptides, a static modification of +57 Da was 
added to all SEQUEST searches when TCEP reduction and CAM treatment were 
performed prior to the digestion procedure.  Additionally, a dynamic addition of +16 Da 
was included to identify oxidized methionine residues when present. 
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RESULTS 
 
I. Rpb3-TAP/Rtr1-HFH Purification 
Rtr1 phosphatase was shown to regulate a key step in the transition of the RNAPII-
CTD phosphorylation state from S5-P to S2-P, which is important for transcription 
elongation and termination in eukaryotes (Mosley et al., 2009).  However, the mechanism 
involved in the recruitment of Rtr1 to RNAPII during transcription is unclear.  
Consequently, three TAP purification experiments were performed in S. cerevisiae that 
expresses various combinations of tagged versions of a RNAPII subunit and Rtr1: Rpb3-
TAP and Rtr1-HFH.  The first purification experiment targeted proteins that interacted 
with Rtr1 when it was not in complex with RNAPII.  In the second experiment, proteins 
were identified that interacted with RNAPII when it was not in complex with Rtr1, and 
the third experiment uncovered proteins that associated with the RNAPII-Rtr1 complex. 
The proteins that were identified in the aforementioned experiments were included in 
the results tables below if at least 2 unique peptides and 100 Peptide Spectral Matches 
(PSMs) were detected following MudPIT-LC/MS analysis.  Table 4 presents a list of 
transcription-relevant proteins in S. cerevisiae, and proteins that were detected from at 
least one unique peptide that were present in Table 4 were included in the results tables as 
well.  Conversely, proteins that were identified by Krogan et al. as common contaminants 
in S. cerevisiae TAP affinity purifications were removed from the Rpb3-TAP/Rtr1-HFH  
results tables presented below (Krogan et al., 2006).  In this work, Krogan and coworkers 
used MALDI and LC/MS to identify contaminant proteins that represented more than 3% 
of 4,562 proteins that were isolated from 2,357 tandem affinity purifications in S. 
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cerevisiae providing a much larger number of purifications to identify common TAP 
contaminants than the studies we performed here. 
 
Table 4. Transcription-relevant proteins.  The descriptions of the protein functions were 
obtained from the Saccharomyces Genome Database (www.yeastgenome.org). 
Gene Protein Description 
YDL140C Rpb1 
(Rpo21) 
RNAPII subunit (largest), phosphorylation of Rpb1-C-
terminal domain (CTD) regulates its association with 
transcription factors 
YOR151C Rpb2 RNAPII subunit, second largest 
YIL021W Rpb3 RNAPII subunit, third largest 
YJL140W Rpb4 RNAPII subunit forms a dissociable complex with Rpb7; 
involved in 3’-end processing factors, translation initiation, 
export on mRNA under stress 
YBR154C Rpb5 Subunit common to RNA polymerase I, II, and III; binds 
DNA 
YPR187W Rpb6 
(Rpo26) 
Subunit common to RNA polymerase I, II, and III 
YDR404C Rpb7 See Rpb4 
YOR224C Rpb8 Subunit common to RNA polymerase I, II, and III 
YGL070C Rpb9 RNAPII subunit, binds DNA 
YOR210W Rpb10 Subunit common to RNA polymerase I, II, and III 
YOL005C Rpb11 RNAPII subunit 
YHR143W-
A 
Rpb12 
(Rpc10) 
Subunit common to RNA polymerase I, II, and III 
YBR279W Paf1 Subunit of PAF complex involved in transcription 
elongation 
YLR418C Cdc73 Subunit of PAF complex involved in transcription 
elongation 
YOR123C Leo1 Subunit of PAF complex involved in transcription 
elongation 
YGL244W Rtf1 Subunit of PAF complex involved in transcription 
elongation 
YOL145C Ctr9 Subunit of PAF complex involved in transcription 
elongation 
YKL139W Ctk1 Catalytic subunit of the C-terminal Repeat Domain Kinase I 
(CTDK-I), CTDK-I phosphorylates the CTD of RNAPII to 
regulate transcription and mRNA 3’-end processing 
YJL006C Ctk2 Regulatory subunit of the C-terminal Repeat Domain 
Kinase I (CTDK-I), CTDK-I phosphorylates the CTD of 
RNAPII to regulate transcription and mRNA 3’-end 
processing 
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Gene Protein Description 
YML112W Ctk3 Subunit (function unknown) of the C-terminal Repeat 
Domain Kinase I (CTDK-I), CTDK-I phosphorylates the 
CTD of RNAPII to regulate transcription and mRNA 3’-end 
processing 
YJR072C Npa3 Member of the GTPase family (has ATPase activity); 
involved in transport of RNAPII to the nucleus; involved in 
cohesion of sister chromatids 
YLR243W NA An essential gene, but of unknown function 
YGR063C Spt4 Forms a complex with Spt5 that is involved in regulating 
RNA polymerase I and II transcription and processing of 
pre-mRNA 
YML010W Spt5 See Spt4; has a CTD that is a substrate for phosphorylation 
YGR116W Spt6 Protein involved in transcription, the maintenance of 
chromatin, and RNA processing 
YGL207W Spt16 With Pob3, forms the heterodimeric FACT complex; 
modifies nucleosomes to provide RNA/DNA polymerases 
access to DNA 
YML069W Pob3 See Spt16 
YPR086W Sua7 Transcription factor TFIIB, a factor required for 
transcription initiation 
YPR133C Spn1 Protein involved in RNAPII transcription 
YDR172W Sup35 eRF3, a translation termination factor eRF3 involved in 
mRNA deadenylation and decay 
YBR143C Sup45 eRF1, a polypeptide release factor involved in translation 
termination 
YDL084W Sub2 Subunit of the TREX complex that is required for mRNA 
export to nucleus; in the DEAD-box RNA helicase 
superfamily, involved in spliceosome assembly 
YGL105W Arc1 Protein that delivers tRNA to methionyl- and glutamyl-
tRNA synthetases 
YER164W Chd1 A protein involved in chromatin remodeling that regulates 
transcription; a component of the SAGA and SLIK 
complexes 
YMR235C Rna1 GTPase activating protein involved in nuclear transport 
YDL074C Bre1 E3 ubiquitin ligase required for transcription, among other 
functions 
YHR168W Mtg2 A putative GTPase 
YGR186W Tfg1 
(Ssu71) 
Largest subunit of TFIIF involved in RNAPII transcription 
initiation and elongation 
YGR005C Tfg2 Subunit of TFIIF involved in RNAPII transcription 
initiation and elongation 
YPL129W Tfg3 
(Taf14) 
Subunit of several complexes: TFIID, TFIIF, INO80, 
SWI/SNF, NuA3; involved in RNAPII transcription 
initiation and modification of chromatin 
YGL043W Dst1 TFIIS, general transcription elongation factor 
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Gene Protein Description 
YPR093C Asr1 A ubiquitin ligase that modifies RNAPII, which contributes 
to its regulation 
YJL168C Set2 A histone methyltransferase that is involved in transcription 
elongation 
YDL115C Iwr1 A RNAPII transport factor 
 
Proteins Identified that Interact with Rtr1 
The results of the Rpb3-TAP/Rtr1-HFH TAP purification that targeted proteins that 
interacted with Rtr1 when it was not in complex with RNAPII are presented in Table 5.  
In all, 66 proteins were detected that interacted with Rtr1 through the detection of at least 
two unique peptides that were present with at least 100 PSMs; all transcription-relevant 
proteins that were identified by at least one unique peptide were also included in Table 5.  
Of the 66 proteins identified, 28 proteins were members of the transcription-relevant list.  
This included all 12 subunits of RNAPII, which should not be present following the IgG-
sepharose purification step (see Discussion). 
 
Table 5. Proteins identified that interacted with Rtr1-HFH when it was not in complex 
with Rpb3-TAP (RNAPII) following tandem affinity purification from S. cerevisiae and 
MudPIT-LC/MS analysis. 
Accession 
 
Description* Coverage # PSMs # Peptides # AAS MW 
gi6323278 Yef3p  30.65 898 27 1044 115.9 
gi6320061 Rpb1; TXN  35.14 736 47 1733 191.5 
gi6319612 Mec1p  36.91 646 62 2368 273.2 
gi6322084 Pfk26p  44.01 624 28 827 93.4 
gi6320987 Rtr1; TXN  44.69 564 12 226 26.2 
gi6321631 Tdh3p  50.30 433 11 332 35.7 
gi6325300 Rpl43ap  29.35 368 3 92 10.1 
gi6323057 Rpl15ap  24.02 323 4 204 24.4 
gi6322468 Tdh2p  46.39 280 10 332 35.8 
gi6325167 Rps6ap  28.81 276 7 236 27.0 
gi6321315 Rps2p  40.16 258 7 254 27.4 
gi6324725 Rpb2; TXN  31.21 252 27 1224 138.7 
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Accession 
 
Description* Coverage # PSMs # Peptides # AAS MW 
gi6322409 Tdh1p  22.29 240 5 332 35.7 
gi6321291 Rpl9ap  39.27 236 6 191 21.6 
gi14318555 Rpl2ap  36.61 226 7 254 27.4 
gi6319282 Fun12p  32.63 222 23 1002 112.2 
gi6324298 Hhf2p  42.72 205 4 103 11.4 
gi6320949 Rps8bp  39.50 205 6 200 22.5 
gi6324262 Rpl9bp  39.27 197 6 191 21.6 
gi6322168 Rpb3; TXN  47.17 193 9 318 35.3 
gi6323654 Clu1p  35.00 188 29 1277 145.1 
gi6320707 Lcd1p  26.64 181 14 747 86.4 
gi6322313 Rpa34p  36.05 176 6 233 26.9 
gi6325036 Rpl1ap  24.88 173 6 217 24.5 
gi6320963 Rpl23bp  16.79 172 2 137 14.5 
gi6323567 Rpl6ap  27.84 160 4 176 19.9 
gi9755341 Rps16ap  48.95 151 7 143 15.8 
gi6320065 Rpl35ap  33.33 144 6 120 13.9 
gi6323226 Nop56p  42.46 142 14 504 56.8 
gi6321968 Eno2p  50.34 142 13 437 46.9 
gi6322847 Rpl14ap  31.16 136 4 138 15.2 
gi6324260 Rpl16bp  28.28 133 7 198 22.2 
gi37362658 Ssz1p  43.49 131 14 538 58.2 
gi86558907 Rhr2p  41.20 125 7 250 27.9 
gi6321754 Rpl8ap  38.67 124 10 256 28.1 
gi6320190 Nop1p  30.28 119 8 327 34.4 
gi6319666 Rps9bp  34.87 117 9 195 22.3 
gi6322271 Rps22ap  42.31 113 5 130 14.6 
gi6324886 Nop58p  35.23 110 12 511 56.9 
gi6321693 Eno1p  41.88 109 11 437 46.8 
gi37362649 Gus1p  21.89 104 13 708 80.8 
gi6321203 Ade5,7p  37.16 103 18 802 86.0 
gi6319630 Rpb5; TXN  33.02 88 5 215 25.1 
gi6324569 Rpb11; TXN  42.50 37 4 120 13.6 
gi6321333 Arc1p; TXN 26.86 33 7 376 42.1 
gi6325445 Rpb6; TXN  14.19 28 1 155 17.9 
gi6324798 Rpb8; TXN  21.23 27 2 146 16.5 
gi6321231 Spt16p; TXN 16.33 25 12 1035 118.6 
gi6324784 Rpb10; TXN  52.86 13 2 70 8.3 
gi330443717 Ctr9; TXN  4.55 11 3 1077 124.6 
gi6321193 Rtf1; TXN  2.69 11 2 558 65.8 
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Accession 
 
Description* Coverage # PSMs # Peptides # AAS MW 
gi6320119 Sub2p; TXN 6.05 9 2 446 50.3 
gi6322321 Rpb4; TXN  23.98 9 4 221 25.4 
gi6321012 Chd1p; TXN 5.86 8 6 1468 168.1 
gi6322532 Npa3p; TXN 9.35 7 3 385 43.2 
gi6321368 Rpb9; TXN  8.20 7 1 122 14.3 
gi6323632 Spt5; TXN  2.73 3 3 1063 115.6 
gi6321625 Tfg1; TXN  1.63 3 1 735 82.1 
gi6319619 Sup45p; 
TXN 
6.18 3 2 437 49.0 
gi6321937 Rpb12; TXN  28.57 3 1 70 7.7 
gi6320612 Rpb7; TXN  9.36 2 1 171 19.0 
gi6320377 Sup35p; 
TXN 
1.61 1 1 685 76.5 
gi6319756 Paf1; TXN  2.92 1 1 445 51.8 
gi6325390 Spn1p; TXN 3.66 1 1 410 46.1 
gi6325128 Taf14; TXN  6.56 1 1 244 27.4 
gi6323272 YLR243W; 
TXN 
4.78 1 1 272 30.6 
*All transcription-relevant proteins that were detected were included (TXN in description) 
Coverage: The total percentage of amino acid sequence identified by matching tryptic peptides 
# PSMs: The number of peptide spectral matches (proteins with <100 PSMs were excluded unless they 
were classified as transcription related -TXN) 
# Peptides: The number of unique peptides that were detected (proteins with <2 were excluded unless they 
were classified as transcription related -TXN) 
# AAS: The number of amino acids in the intact protein 
MW: The protein molecular weight (kilodaltons) 
 
Proteins Identified that Interact with RNAPII 
RNAPII and associated proteins were eluted from the calmodulin resin, the last step 
of the TAP purification that targets RNAPII, by five aliquots of Calmodulin Elution 
Buffer containing EGTA.  These calmodulin elutions were analyzed by SDS-PAGE with 
silver staining to evaluate the yield of the purification as determined by the presence and 
intensity of the RNAPII subunits (Figure 8).  Elution two and three were found to provide 
the best recovery of RNAPII subunits, and all twelve subunits were present including 
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phosphorylated Rpb1 as determined by comparison to previously obtained silver-stained 
gels for RNAPII purifications (Mosley et al., 2011). 
The results of the Rpb3-TAP/Rtr1-HFH TAP purification that targeted proteins that 
interacted with RNAPII when it was not in complex with Rtr1 are presented in Table 6.  
A total of 14 proteins that satisfied the aforementioned criteria were detected by MudPIT-
LC/MS.  Among the list was a single protein, Dbp2, that is not a member of the 
transcription-relevant list (see Table 4) and was identified by more than two unique 
peptides having greater than 100 PSMs.  Additionally, eight of the twelve RNAPII 
subunits were detected by MudPIT-LC/MS (Rpb6, Rpb9, Rpb10, and Rpb12 were 
absent), as well as four additional transcription-relevant proteins. 
 
 
Figure 8. SDS-PAGE analysis with silver staining showing RNAPII subunits.  The 
RNAPII subunits were present in the Rpb3-TAP/Rtr1-HFH purification scheme targeting 
proteins that interact with RNAPII in the absence of Rtr1. 
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Table 6. Proteins identified that interacted with Rpb3-TAP (RNAPII) when not in 
complex in Rtr1 
Accession 
 
Description* Coverage # PSMs # Peptides # AAs MW 
gi6320061 Rpb1p; TXN 20.95 3153 32 1733 191.5 
gi6324725 Rpb2p; TXN 20.18 1647 22 1224 138.7 
gi6322321 Rpb4p; TXN 22.62 647 4 221 25.4 
gi6322168 Rpb3p; TXN 8.18 515 2 318 35.3 
gi6324569 Rpb11p; TXN 31.67 464 4 120 13.6 
gi6324798 Rpb8p; TXN 21.23 457 2 146 16.5 
gi6319630 Rpb5p; TXN 12.09 292 2 215 25.1 
gi6324217 Dbp2p 18.86 122 9 546 61.0 
gi6323632 Spt5p; TXN 10.82 88 9 1063 115.6 
gi6320612 Rpb7p; TXN 7.60 44 1 171 19.0 
gi6325390 Spn1p; TXN 14.15 14 4 410 46.1 
gi6321231 Spt16p; TXN 1.35 3 1 1035 118.6 
gi6321333 Arc1p; TXN 3.46 1 1 376 42.1 
gi6321552 Spt6p; TXN 1.10 1 1 1451 168.2 
*All transcription-relevant proteins that were detected were included (TXN in description) 
Coverage: The total percentage of amino acid sequence identified by matching tryptic peptides 
# PSMs: The number of peptide spectral matches (proteins with <100 PSMs were excluded unless they 
were classified as transcription related -TXN) 
# Peptides: The number of unique peptides that were detected (proteins with <2 were excluded unless they 
were classified as transcription related -TXN) 
# AAS: The number of amino acids in the intact protein 
MW: The protein molecular weight (kilodaltons) 
 
Proteins Identified that Interact with the RNAPII-Rtr1 Complex 
The results of the Rpb3-TAP/Rtr1-HFH TAP purification that targeted proteins that 
interacted with the RNAPII-Rtr1 complex are presented in Table 7.  A total of 26 proteins 
were identified that satisfied the criteria of having at least 2 unique peptides detected that 
had at least a total of 100 PSMs.  An additional 6 proteins were included in Table 7 that 
did not meet the inclusion criteria but were members of the transcription-relevant list 
presented in Table 4.  In all, 8 of the RNAPII subunits were detected; Rpb4, Rpb6, and 
Rpb7 were not detected.  Furthermore, 9 of the proteins that were found to interact with 
the RNAPII-Rtr1 complex were not members of the transcription-relevant list. 
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Table 7. Proteins identified that interacted with the RNAPII-Rtr1 complex 
Accession 
 
Description* Coverage # PSMs # Peptides # AAs MW 
gi6320061 Rpb1; TXN  24.75 801 32 1733 191.5 
gi6324725 Rpb2; TXN  28.68 550 27 1224 138.7 
gi6323278 Yef3p  26.15 532 19 1044 115.9 
gi6320987 Rtr1; TXN  45.13 270 8 226 26.2 
gi6322168 Rpb3; TXN  43.40 238 7 318 35.3 
gi6324298 Hhf2p  50.49 213 5 103 11.4 
gi6324886 Nop58p  27.40 178 10 511 56.9 
gi6325167 Rps6ap  23.31 177 4 236 27.0 
gi37362649 Gus1p  26.98 138 14 708 80.8 
gi6319559 Rpl19ap  29.10 135 5 189 21.7 
gi6320190 Nop1p  27.83 117 8 327 34.4 
gi6323654 Clu1p  17.85 104 16 1277 145.1 
gi6319378 Rpl32p  23.85 100 3 130 14.8 
gi6324569 Rpb11; TXN  42.50 71 4 120 13.6 
gi6319630 Rpb5; TXN  28.84 68 4 215 25.1 
gi6324798 Rpb8; TXN  21.23 49 2 146 16.5 
gi6324784 Rpb10; TXN  52.86 36 2 70 8.3 
gi6321333 Arc1p; TXN 11.97 35 4 376 42.1 
gi6321231 Spt16p; TXN 5.12 17 4 1035 118.6 
gi6321937 Rpb12; TXN  28.57 11 1 70 7.7 
gi6322532 Npa3p; TXN  3.64 9 1 385 43.2 
gi6323632 Spt5; TXN  2.54 2 2 1063 115.6 
gi6320129 Bre1p; TXN 1.29 2 1 700 80.6 
gi6321368 Rpb9; TXN  17.21 1 1 122 14.3 
gi6323571 Pob3p; TXN 1.63 1 1 552 63.0 
gi6323272 YLR243W; 
TXN 
4.78 1 1 272 30.6 
*All transcription-relevant proteins that were detected were included (TXN in description) 
Coverage: The total percentage of amino acid sequence identified by a matching tryptic peptide 
# PSMs: The number of peptide spectral matches (proteins with <100 PSMs were excluded unless they 
were classified as transcription related -TXN) 
# Peptides: The number of unique peptides that were detected (proteins with <2 were excluded unless they 
were classified as transcription related -TXN) 
# AAS: The number of amino acids in the intact protein 
MW: The protein molecular weight (kilodaltons) 
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II. Rtr1-1XFLAG Purification 
Proteins Identified that Interact with Rtr1 
The next experiment that was designed to identify proteins that interacted with Rtr1 
that might plan a role in the recruitment of Rtr1 to RNAPII was performed in S. 
cerevisiae that expressed a 1XFLAG-tagged version of Rtr1 (Rtr1-1XFLAG, see Table 
2).  This experiment relied on a single affinity purification step with anti-FLAG resin to 
co-immunoprecipitate Rtr1 and its interacting partners from S. cerevisiae lysate followed 
by their detection by MudPIT-LC/MS.  In the same fashion as the Rpb3-TAP/Rtr1-HFH 
experiments, proteins were only included in the results table (Table 8) if they were 
detected by the presence of at least 2 unique peptides and at least 100 PSMs.  
Furthermore, all transcription-relevant proteins (Table 4) were included in the results 
table, and any contaminant proteins were excluded. 
The results of the Rtr1-1XFLAG single purification are presented in Table 8, which 
includes 2 proteins, in addition to Rtr1, that met the inclusion criteria, and an additional 9 
proteins that were included because they were members of Table 4.  Among the detected 
proteins were RNAPII subunits (Rpb1, Rpb2, Rpb5, Rpb6, Rpb10) as well as proteins 
that were not part of the list of transcription-relevant proteins: Mec1, Hyp2. 
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Table 8. Proteins identified that interacted with Rtr1 
Accession 
 
Description* Coverage # PSMs # Peptides # AAs MW 
gi6319612 Mec1p  13.51 145 20 2368 273.2 
gi6320801 Hyp2p  19.11 124 2 157 17.1 
gi6320987 Rtr1; TXN  56.19 117 11 226 26.2 
gi6320061 Rpb1; TXN  6.35 20 8 1733 191.5 
gi6324725 Rpb2; TXN  4.58 13 3 1224 138.7 
gi6325445 Rpb6; TXN  14.19 3 1 155 17.9 
gi6321193 Rtf1; TXN  6.81 2 2 558 65.8 
gi6324784 Rpb10; TXN  37.14 2 1 70 8.3 
gi6319630 Rpb5; TXN  7.91 1 1 215 25.1 
gi6320377 Sup35p; TXN 1.90 1 1 685 76.5 
gi6321368 Rpb9; TXN  20.49 1 1 122 14.3 
gi330443587 Mtg2p; TXN 6.37 1 1 518 57.8 
*All transcription-relevant proteins that were detected were included (TXN in description) 
Coverage: The total percentage of amino acid sequence identified by matching tryptic peptides 
# PSMs: The number of peptide spectral matches (proteins with <100 PSMs were excluded unless they 
were classified as transcription related -TXN) 
# Peptides: The number of unique peptides that were detected (proteins with <2 were excluded unless they 
were classified as transcription related -TXN) 
# AAS: The number of amino acids in the intact protein 
MW: The protein molecular weight (kilodaltons) 
 
III. Scaffold Data Analysis 
The computer program Scaffold™ (hence referred to as Scaffold) is a tool used by 
proteomics researchers to integrate protein data generated following a search using a 
combination of three common MS-based proteomics search algorithms (SEQUEST, 
X!tandem, Mascot) (NRPP, 2008).  Upon integrating MS results from proteins identified 
in different experiments, Scaffold generates peptide and protein identification 
probabilities and recalculates false discovery rates based on the Peptide Prophet 
algorithm (Keller et al., 2002).  Furthermore, as in the work presented here, Scaffold can 
align hundreds of proteins identified in single and double purifications schemes that 
originated from both experimental and mock preparations. 
In order to increase the confidence that the proteins detected in the RNAPII-Rtr1 
double purification, and the Rtr1 single purification, experiments were associated with 
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Rtr1 and/or RNAPII, all of the MudPIT-LC/MS data from both experimental and mock 
preparations were subjected to a Scaffold analysis.  This included data from experimental 
and mock samples from Rtr1-TAP (Mosley Lab, Indiana University), Rtr1-1XFLAG, and 
Rpb3-TAP/Rtr1-HFH purification schemes.   
After performing the Scaffold analysis, normalized spectral abundance factors 
(NSAF) were calculated using Equation I and Microsoft Excel as previously described 
(Zhang et al., 2010; Zybailov et al., 2006); PSM is the number of spectrum-peptide 
matches for a given protein, Length is the length of the protein in amino acids, k 
represents all proteins identified in the purification, and N is the total number of proteins 
identified.  PSM is an indication of protein abundance as measured using mass 
spectrometry; however, larger proteins tend to generate more proteolytic fragments upon 
digestion.  Therefore, NSAF values are a way to normalize PSM values obtained from a 
protein by considering its length and then putting all PSM/Length values for all proteins 
detected in a sample on a scale from 0-1(hence normalizing the values).    
Equation I 𝑁𝑆𝐴𝐹𝑖 = !"#!"#$%! !(!!!! !"#/!"#$%!)! 
To be included in the results table (Table 9), proteins had to identified by MudPIT-
LC/MS with at least 20 total peptide counts, and a protein had to be enriched by at least 
2-fold over the relevant mock preparation (i.e. NSAFexp/NSAFmock >2). 
The results of the Scaffold analysis are presented in Table 9.  The first column of data 
presents all proteins that were detected across all of the different purification schemes as 
Rtr1-interacting proteins.  All twelve of the RNAPII subunits were detected with the 
exception of Rpb4, Rpb6, Rpb7, and Rpb9.  Thirteen additional proteins were also 
detected that included transcription-relevant proteins (Table 4) Npa3 and two subunits of 
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the PAF complex (Cdc73, Ctr9).  In the second column, proteins that were enriched 
greater than 2-fold in the RNAPII-Rtr1 double purifications are listed.  This column 
should be enriched in proteins that are required for Rtr1 recruitment to RNAPII.  As with 
the first column, the same set of RNAPII subunits were detected along with 8 additional 
proteins, all of which were common to the first column.  Npa3 was the only protein 
detected in the double purifications, other than RNAPII subunits), that was a member of 
the transcription-relevant proteins listed in Table 4.  Likewise, column three lists the 
proteins that were greater than 2-fold enriched in the Rtr1-TAP and Rtr1-1XFLAG single 
purification experiments specifically.  In all, 8 proteins were detected including three 
PAF complex subunits (Cdc73, Ctr9, Leo1).  Four proteins listed in Table 9 (Rpb8, 
Rpb12, Spn1, Rpa49) were not detected in the mock purification experiments. 
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Table 9. Proteins that co-purified with Rtr1 following tandem affinity purification; single 
and double affinity purifications that were enriched 2-fold over protein from mock 
purifications 
Proteins Identified# 
(all purification schemes) 
Proteins Enriched ≥2-fold 
(Rtr1-RNAPII double 
purifications) 
Proteins Enriched ≥2-fold 
(Rtr1 single purifications) 
Rpb1* Rpb1*  
Rpb10* Rpb10*  
Rpb11* Rpb11*  
Rpb12*† Rpb12*†  
Rpb2* Rpb2*  
Rpb3* Rpb3*  
Rpb5* Rpb5*  
Rpb8*† Rpb8*†  
Hhf2 Hhf2  
Npa3 Npa3  
Prp22 Prp22  
Rad9 Rad9  
Rpa34 Rpa34  
Rpc53 Rpc53  
Rpt6 Rpt6  
Ssn2 Ssn2  
Cdc73  Cdc73 
Ctr9  Ctr9 
Gal11  Gal11 
Hsc82  Hsc82 
Nut1  Nut1 
  Spn1† 
  Rpa49† 
  Leo1 
#Proteins identified with <20 total peptide counts were rejected 
*RNAPII subunits 
†Not detected in MOCK purifications 
 
IV. Post-translational Modification of Rtr1 
To help clarify if post-translational modification of Rtr1 plays a role in its recruitment 
to RNAPII, MudPIT-LC/MS spectra obtained from the Rtr1-TAP single purification 
were searched using the SEQUEST.  The data obtained from Rtr1-TAP was analyzed for 
the presence of the following PTMs: phosphorylation of Ser, Thr, and Tyr, which will 
result in a mass shift of 80 daltons per phosphorylation site on the peptide.  The PTM 
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search result is presented in Figure 9, which indicates the presence of a phosphorylation 
site at Rtr1 Ser217.  The MS/MS spectrum of the phosphorylated tryptic peptide 
IVENDNPSILGDFTR (Figure 9, pane D) shows an extensive and diagnostic neutral loss 
of 98 da (phosphoric acid) from the parent [M+2H]+2 ion. 
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Figure 9.  LC/MS identification of Rtr1 phosphorylation site at Ser217 (Berna et al., 
2011).  (A) Schematic representation of Saccharomyces cerevisiae yeast Rtr1 with 
sequence coverage indicated in blue and the position of the phosphorylation site in red.  
(B) Sequence of tryptic peptide containing the site of phosphorylation with every other y- 
and b-ion indicated.  (C) MS/MS spectrum obtained from the unmodified Rtr1 tryptic 
peptide IVENDNPSILGDFTR.  (D) MS/MS spectrum of phosphorylated (Ser217) Rtr1 
tryptic peptide indicating the signature neutral loss of 98 daltons from the parent 
[M+2H]+2 ion. 
 
V. CTDK1-TAP/Rtr1-V5 Purification 
Fasolo et al. reported the interaction between the CTDK-I complex and Rtr1 in 2011 
(Fasolo et al., 2011).  Because of the involvement in CTDK-I in the regulation of 
RNAPII transcription, and its role in recruiting factors to RNAPII, it was hypothesized 
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that CTDK-I plays a role in the recruitment of Rtr1 to RNAPII during transcription.  
Consequently, single and double affinity purifications of S. cerevisiae that express TAP-
tagged versions of CTDK-I subunits (Ctk1, Ctk2), and V5-tagged Rtr1, were performed 
to confirm the interaction between Rtr1 and CTDK-I.  Following the purification 
schemes as described in the methods section, the presence or absence of specific CTDK-I 
subunits and Rtr1 were analyzed by Western blot. 
Interaction of CTDK-I and Rtr1, Single Purification 
The results of the IgG-sepharose single purification that targeted Ctk1-TAP or Ctk2-
TAP, and Rtr1 if it was found to interact with CTDK-I, are presented in Figure 10.  Ctk1 
was identified in the Ctk1-Input sample, but an interaction between Ctk1 and Rtr1 was 
not observed.  Rtr1 was not identified in the Ctk2-Input sample (result not shown), which 
invalidated this portion of the experiment and indicated that the Ctk2-TAP strain was 
incorrect. 
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Figure 10. Western blot analysis of the CTDK-I subunit Ctk1 and Rtr1 following a single 
affinity purification targeting Rtr1-V5 and interacting proteins.  The blue arrow indicates 
the position of Ctk1-TAP in the Ctk1 input sample, and the red arrow indicates the 
position of Rtr1-V5 in the Ctk1 input sample.  The percentage of the input samples and 
IP samples loaded to the protein gel were 0.05% and 25%, respectively. 
 
Interaction of CTDK-I and Rtr1, Double Purification 
The results of the IgG-sepharose and anti-FLAG double purification that targeted 
Ctk1-TAP, Ctk2-TAP, and Rtr1 are presented in Figure 11.  Both Ctk1 and Rtr1 were 
identified in the Ctk1-Input sample, but an interaction between Ctk1 and Rtr1 was not 
observed indicating that Rtr1 and Ctk1 do not interact at significant levels in vivo.  
Additionally, Ctk2 was identified in the Ctk2-Input, but Rtr1 was not detected in the 
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Ctk2-Input, so the interaction between CTDK-I and Rtr1 could not be confirmed from 
this part of the experiment. 
 
 
 
Figure 11. Western blot analysis of CTDK-I subunits (Ctk1 and Ctk2) and Rtr1 following 
a double affinity purification targeting Ctk1-TAP, Ctk2-TAP, and Rtr1-V5.  The blue 
arrows indicate the position of Ctk2-TAP in the Ctk2 input sample and Ctk1-TAP in the 
Ctk1 input sample.  The red arrow indicates the position of Rtr1-V5 in the Ctk1 input 
sample.  The percentage of the input samples and IP samples loaded to the protein gel 
were 0.05% and 25%, respectively. 
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Effect of ctk1Δ on Rtr1 Interactions 
Although the in vivo interaction between Rtr1 and CTDK-I was not confirmed in the 
work presented here, there interaction was previously reported using an in vitro approach 
to maximize kinase-interacting partner interactions (Fasolo et al., 2011).  Therefore, the 
effect of ctk1Δ on Rtr1 interactions with RNAPII and transcription factors, and on the 
phosphorylation of Rtr1 was studied.  S. cerevisiae that expressed Rtr1-TAP in a CTK1  
deletion genetic background (ctk1Δ ) were purified using a TAP purification scheme.  In 
the first part of the experiment, protein-protein interactions between Rtr1, RNAPII 
subunits, and transcription factors known to associate with Rtr1 Ser217 peptides was 
dramatically reduced in the absence of Ctk1 (Figure 12).  Likewise, following post-
translational modification searches for phosphorylation, the number of phosphorylated 
Rtr1 peptides was dramatically reduced in Rtr1-TAP ctk1Δ versus wild-type Rtr1-TAP 
(Figure 13). 
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Figure 12. Effect of ctk1Δ on Rtr1 interactions with RNAPII and transcription factors 
(Berna et al., 2011).  The spectral abundance factors of RNAPII subunits and 
transcription factors known to associate with Rtr1 were reduced in ctk1Δ versus wild-type 
S. cerevisiae as determined by LC/MS. 
 
 
 
Figure 13. Effect of ctk1Δ on Rtr1 serine-217 phosphorylation (Berna et al., 2011).  The 
presence of Rtr1 serine-217 phosphorylation was reduced in ctk1Δ versus wild-type S. 
cerevisiae as determined by LC/MS. 
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DISCUSSION 
 
I. Rpb3-TAP/Rtr1-HFH Purification Scheme 
In an effort to identify novel proteins responsible for recruiting Rtr1 phosphatase to 
RNAPII during transcription, we devised a tandem affinity purification scheme using a 
yeast strain that expressed Rtr1-HFH and a TAP-tagged version of the RNAPII subunit, 
Rpb3.  The purification was designed to target proteins that interact with Rtr1 in the 
presence and absence RNAPII, as well as proteins that interact with RNAPII in the 
absence of Rtr1 (see Figure 14). 
To isolate proteins that interact with Rtr1 alone, IgG-sepharose was used to remove 
RNAPII, through the interaction with the Protein-A portion of the Rpb3 TAP tag, from 
the S. cerevisiae extract.  Next, Rtr1 and interacting proteins were isolated using anti-
FLAG resin to target the 3XFLAG portion of the Rtr1-HFH tag.  Following the affinity 
purification, the proteins were digested with trypsin and were identified by MudPIT-
LC/MS.  The results of the analysis are presented in Table 5, and it was noted that the 
purification was contaminated by all twelve of the RNAPII subunits.  It was initially 
hypothesized that there was insufficient IgG-sepharose to remove all of the RNAPII from 
the sample; however, the same results was achieved upon repeating the purification with 
a 2-fold increase in the volume of IgG-sepharose resin used.  Consequently, a second 
hypothesis was proposed that the S. cerevisiae used in the purification expressed both 
wild-type and TAP-tagged RNAPII (via the Rpb3 subunit).  A PCR experiment was 
designed using primers that would generate products that could be used to differentiate 
Rpb3-TAP from wild-type Rpb3 following agarose gel electrophoresis.  However, 
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following PCR analysis of genomic DNA isolated from the S. cerevisiae, no PCR 
products were obtained.  The experiment was repeated with the same result and was 
therefore inconclusive (data not shown).  Although the preparation was contaminated by 
RNAPII subunits, the data obtained were still useful to identify proteins that interact with 
the RNAPII-Rtr1 complex. 
 
 
Figure 14.  Overview of the Rpb3-TAP/Rtr1-HFH purification scheme.  The purification 
was broken down into three sections that targeted proteins that interacted with: proteins 
that interacted with Rtr1 alone (4A2), proteins that interacted with RNAPII alone (7B), 
and proteins that interacted with the RNAPII-Rtr1 complex (5B2, 5B3). 
 
Eighty-nine proteins, including Rtr1 and nine of the twelve RNAPII subunits, were 
reported in Table 5 that were found to interact with the RNAPII-Rtr1 complex; the focus 
of this branch of the purification was changed due to the aforementioned contamination 
by RNAPII subunits.  Some of the notable proteins that were detected were PAF complex 
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subunits (Ctr9, Rtf1, and Paf1), the ATPase Npa3, the essential protein YLR243W, the 
FACT complex subunit Spt16; and Chd1, which is involved in chromatin remodeling and 
transcription regulation.  All of the proteins detected in this experiment were included in 
a Scaffold analysis to determine their level of enrichment relative to mock preparations.  
Additionally, the results of the Scaffold analysis identified which of the proteins present 
in Table 5 were shown to consistently interact with RNAPII-Rtr1 across the different 
purification schemes reported herein. 
In the second arm of the Rpb3-TAP/Rtr1-HFH purification scheme, proteins that 
interacted with RNAPII alone were targeted.  RNAPII and interacting proteins were 
isolated from the cell lysate using IgG-sepharose, and Rtr1 was removed from this 
fraction using anti-FLAG resin.  RNAPII and its interacting partners were further purified 
using calmodulin resin to target the calmodulin binding protein portion of the Rpb3-TAP 
tag.  Following immunoprecipitation, the RNAPII subunits in the sample were analyzed 
by SDS-PAGE with silver staining (Figure 8), and a second aliquot of the affinity-
purified sample was digested with trypsin and analyzed by MudPIT-LC/MS (Table 6).  
Rtr1 was not detected in this purification scheme, which served as a negative control by 
verifying its removal using anti-FLAG resin. 
It was concluded from the SDS-PAGE analysis of the RNAPII subunits that the 
purification scheme had good yield; all twelve of the RNAPII subunits were detected.  In 
addition to RNAPII subunits, nine other proteins were included in the results presented in 
Table 6 including Spt5, which has a CTD similar to Rpb1 that is a substrate for 
phosphorylation.  The finding that Spt5 associates with RNAPII at high levels 
corroborates the same observation that was made by Mosley et al. in 2011 (Mosley et al., 
60 
	  
	  
2011).  Therein, the authors used label free quantitative proteomics to study RNAPII 
complexes, and they reported that Spt5 was one of the most abundant proteins found to 
associate with RNAPII.  In addition, the transcription factors Spt6 and Spn1 were 
detected, as was the FACT subunit Spt16, and Arc1, which is involved in tRNA delivery 
to tRNA synthetases.  In addition to the proteins presented in Table 6, all of the proteins 
detected in this branch of the purification scheme were included in the Scaffold analysis 
to determine their level of enrichment relative to mock preparations. 
The final targets of the Rpb3-TAP/Rtr1-HFH purification were proteins that 
interacted with the RNAPII-Rtr1 complex.  In this purification, RNAPII-Rtr1 was 
isolated from yeast lysate first by using IgG-sepharose to target Rpb3-TAP followed by a 
second immunoprecipitation using anti-FLAG resin to target Rtr1-HFH. 
In addition to nine of the twelve RNAPII subunits and Rtr1, thirty-six proteins that 
were detected were included in the results presented in Table 7.  In effect, this experiment 
was a repeat of the experiment that was intended to identify proteins that interacted with 
Rtr1 alone; however, that experiment was contaminated by the presence of RNAPII 
subunits (Table 5).  Consequently, many of the same proteins were detected in this 
experiment as well, including YLR243W, Npa3, Spt16, and Arc1.  Discounting Rtr1 and 
RNAPII subunits, seven transcriptionally relevant proteins were detected.  As with the 
other Rpb3-TAP/Rtr1-HFH purification schemes, all of the proteins that were detected 
were included in the Scaffold analysis. 
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II. Rtr1-1XFLAG Purification Scheme 
A single affinity purification scheme was performed in S. cerevisiae that expressed 
Rtr1-1XFLAG.  By substituting the relatively simple anti-FLAG purification for the more 
complex tandem affinity purification, a wider net was cast in an effort to identify a larger 
range of proteins that may play a role in the recruitment of Rtr1 to RNAPII during 
transcription (see Figure 6).  By reducing the number of purification steps, the Rtr1-
FLAG single purification has the potential for increased background relative to the TAP 
purification scheme; however, Scaffold analysis was used to help identify non-specific 
Rtr1-interacting partners by measuring their level of enrichment relative to mock 
preparations. 
The results of the Rtr1-1XFLAG purification are presented in Table 8.  In addition to 
Rtr1 and six of the twelve RNAPII subunits, Mec1, Hyp2, Ssa1, and Ssa2 were detected 
with greater than 100 PSMs, and with the exception of Hyp2, greater than eight unique 
peptides.  However, it should be noted that Hyp2 is relatively small (157 amino acid 
residues), which may help to explain the limited number of unique peptides that were 
detected.  The proteins Sup35, Mtg2, and the PAF complex subunit Rtf1 were also 
detected, but with poor yield (≤2 PSMs and Unique Peptides).  As with the Rpb3-
TAP/Rtr1-HFH tandem affinity purification, all of the proteins detected in this 
experiment were included in the Scaffold analysis discussed in the following section. 
 
III. Scaffold Data Analysis 
Scaffold Analysis Reveals 21 Proteins that Interact with RNAPII or Rtr1 
As previously discussed, all of the proteins that were detected in the MudPIT-LC/MS 
analyses of Rtr1-TAP and Rtr1-1XFLAG single affinity purifications, and Rpb3-
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TAP/Rtr1-HFH double purifications, were analyzed using the program Scaffold.  
Scaffold analysis allowed the side-by-side comparison of tandem mass spectrometry 
results from proteins that were detected in the experimental affinity-based preparations to 
determine their level of enrichment versus mock preparations (i.e. from strains that do not 
contain affinity-tagged proteins).  The level of protein enrichment was determined by 
dividing NSAF values (Equation 1) from proteins enriched in experimental preparations 
by those from their respective mock preparations.  Twenty-one proteins that were 
detected with at least twenty total peptide counts were presented in the Scaffold results 
table (see Table 9).  Additionally, proteins that were enriched by greater than or equal to 
2-fold versus their respective mock preparations were distinguished in Table 9 by the 
type of affinity purification from which they were recovered (i.e. Rtr1-RNAPII double 
purifications or Rtr1 single purifications). 
The first column in Table 9 lists the proteins that were identified in all of the 
aforementioned purification schemes.  This included, as expected, the RNAPII subunits 
Rpb1-3, Rpb5, Rpb8 and Rpb10-12.  Rpb4, Rpb6, Rpb7, and Rpb8 were not detected (i.e. 
they were present with less than 20 total peptide counts).  However, this can be explained 
by the fact that Rpb4, Rpb7, and Rpb9 were found to have decreased association with 
Rtr1; and Rpb6, Rpb8 are difficult to detect by mass spectrometry (Mosley et al., 2012; 
Mosley et al., 2011).  The same RNAPII subunits listed herein were found to be greater 
than 2-fold enriched in the Rtr1-RNAPII double purifications as well.  In fact, the results 
of the different purification schemes indicate that the most significant Rtr1 interacting 
partners identified were RNAPII subunits.  In the Rbp3-TAP/Rtr1-HFH double 
purifications, Rpb1, Rpb2, Rpb3, and Rpb4 were part of the top six most abundant 
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proteins found to interact with Rtr1 (Tables 5 and 7).  Similarly, Rpb1, Rpb2, and Rpb6 
were among the top 5 most abundant proteins found to interact with Rtr1 in the Rtr1-
1XFLAG single purification experiment (Table 8).  Figure 15 shows the level of Rtr1 
enrichment, relative to the RNAPII subunits Rpb1 and Rpb2, achieved using Rtr1-TAP 
and Rtr1-FLAG single purifications; and Rpb3-TAP/Rtr1-HFH double purification 
schemes. 
Proteins that were Greater than 2-Fold Enriched in Rtr1-RNAPII Double Purifications 
Sixteen proteins identified in the Scaffold analysis were found to be greater than 2-
fold enriched in the Rtr1-RNAPII double purification schemes relative to their respective 
mock preparations.  These included ten proteins that were RNA polymerase subunits, 
which suggests that RNAPII subunits may play the most important role in recruiting Rtr1 
during transcription.  As mentioned before, eight of these proteins were RNAPII 
subunits.  Other RNA polymerase subunits were also detected.  Rpc53, also known as 
Rpc4, is an RNA polymerase III subunit (Kassavetis et al., 2010), and Rpa34 is a RNA 
polymerase I subunit (Albert et al., 2011).  It is unlikely that RNA polymerase I and III 
subunits are involved in recruiting Rtr1 to RNAPII. 
The protein Histone H4 (Hhf1, Hhf2) was greater than 2-fold enriched in the Rtr1-
RNAPII double purifications and is described in the Saccharomyces Genome Database 
(SGD, www.yeastgenome.org) as being required for the assembly of chromatin.  The 
human homolog is encoded by the gene KCNJ11 and is known as Hist2H4B protein.  As 
a histone core protein, it is reasonable that Hhf2 would be found to associate with 
RNAPII as they both interact with DNA.  The interaction with DNA and Rtr1 is likely 
indirect via RNAPII, so it is possible that Rtr1 might not interact directly with Histone 
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H4.  This is supported by the fact that Histone H4 was not enriched in the Rtr1single 
purification schemes. 
Npa3 was greater than 2-fold enriched in the Rtr1-RNAPII double purifications but 
was absent in the Rtr1single purifications.  This protein is a cytoplasmic protein that 
binds to RNAPII in a GTP-dependent fashion and was found to participate in its transport 
to the nucleus (Staresincic et al., 2011).  Staresincic et al. reported that depletion of Npa3 
in yeast resulted in the build-up of RNAPII in the cytoplasm and a corresponding 
decrease in the transcription of numerous genes as measured by clonal sequencing and 
RT-PCR (Staresincic et al., 2011); compared to wild-type Npa3, a temperature sensitive 
strain resulted in at least a 2-fold change in expression of 1392 genes, with 1294 of these 
being down-regulated.  XAB1, the human homolog of Npa3, was found to interact with 
human RNAPII in a similar fashion (Staresincic et al., 2011).  It is possible that the role 
that Npa3 plays in importing RNAPII into the nucleus might also signal the recruitment 
of Rtr1.  Interestingly, the human homolog of Rtr1, RPAP2, was found to translocate 
between the nucleus and the cytoplasm (Boulon et al., 2010), and it was proposed that 
RPAP2 might serve to keep RNAPII in a hypophosphorylated state to prevent the 
recruitment of RNA processing factors and the resulting, premature processing of RNA 
(Corden, 2011). 
The DEAH-box RNA helicase Prp22 is an ATPase that catalyzes the release of 
mRNA from the spliceosome during pre-mRNA splicing (Schwer, 2008).  Prp22 was 
enriched in the Rtr1-RNAPII double affinity purification but not in the Rtr1 single 
purification schemes. The fact that Prp22 was not found to directly interact with Rtr1, and 
that it functions primarily to release mRNA from the spliceosome as opposed to affecting 
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its elongation, makes it unlikely that Prp22 is involved in the recruitment of Rtr1 to 
RNAPII during transcription elongation. 
Checkpoints proteins are involved in regulating cell cycle checkpoints, which are 
signaling pathways that delay progression through the cell cycle in response to DNA 
damage or defective chromosomal replication (Labib and De Piccoli, 2011).  The 
checkpoint protein Rad9 was enriched in the Rtr1-RNAPII double purifications.  Rad9 is 
specifically involved in DNA damage repair and forms a ternary complex with the 
proteins Dpb11 and Mec1 (Pfander and Diffley, 2011).  Based on the role of Rad9, it is 
not a primary candidate as a protein involved in recruiting Rtr1 to RNAPII. 
Rpt6 was also found to be enriched in the present experiment and is one of six 
ATPases that are components of the regulatory particle of the 26S proteasome, which in 
eukaryotic cells degrades ubiquitinated proteins (Lee et al., 2012).  In 2002, Ferdous et 
al. reported that the 19S regulatory particle of the proteasome plays an important, 
nonproteolytic role in the efficient initiation of transcription by human RNAPII (Ferdous 
et al., 2002).  Furthermore, the authors reported that this function was general to all 
eukaryotes.  The human homolog of Rpt6 is known as p45 and serves a similar function 
in the human 26S proteasome (Satoh et al., 2001). 
The final protein found to be enriched in this purification scheme was Ssn2 
(Srb9/Med13).  Ssn2 protein was found to be identical to Srb9, a component of the 
mediator complex that interacts with RNAPII to mediate transcription activation and 
repression in S. cerevisiae (Song et al., 1996).  More recently, Wery et al. reported that 
Srb9 (now Med13) associates with TFIIS, a transcriptional elongation factor, via its N-
terminal domain (Wery et al., 2004).  Furthermore, The role that Med13 plays in the 
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mediator complex is conserved in humans, and the human homolog of Med13 has the 
same designation (Belakavadi and Fondell, 2010).  Unfortunately, Svejstrup et al. 
reported that Mediator was unable to bind to hyperphosphorylated RNAPII, and that as a 
result, Mediator was found to dissociate from RNAPII during transcription elongation 
(Svejstrup et al., 1997).  Consequently, Mediator subunits are unlikely to be involved in 
recruiting Rtr1 to RNAPII during transcription elongation.  Two additional Mediator 
subunits, Gal11 (Med15) and Nut1 (Med5) were similarly enriched in the Rtr1 single 
purification schemes. 
Proteins that were Greater than 2-Fold Enriched in Rtr1 Single Purifications 
Eight proteins were enriched in the Rtr1 single purification schemes relative to their 
respective mock preparations.  Among them were three of the five subunits of the PAF 
complex, Cdc73, Ctr9, and Leo1.  Mueller and Jaehning previously reported that PAF 
subunits were found to associate with RNAPII throughout the cycle of mRNA 
transcription (Mueller and Jaehning, 2002; Mueller et al., 2004); however, although PAF 
subunits were present, they were not found to be greater than 2-fold enriched in the Rtr1-
RNAPII double purification schemes.  As previously described, PAF associates with an 
impressive list of transcription factors and thereby plays a role in regulating RNAPII 
transcription (Krogan et al., 2002; Mueller and Jaehning, 2002; Squazzo et al., 2002).  
PAF may also serve as a scaffold for the recruitment of transcription factors during 
transcription elongation (Gerber and Shilatifard, 2003; Penheiter et al., 2005), which 
makes PAF a candidate involved in the recruitment of Rtr1 to the RNAPII complex. 
Eukaryotic cells are capable of inducing the expression of heat shock genes as a 
protective mechanism to counter the effects of elevated temperatures.  One such gene, 
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Hsc82, encodes a protein that was enriched in the current purification scheme (Hsp90).  
S. cerevisiae have two genes that encode isoforms of Hsp90, namely Hsc82 and Hsp82; 
the former is constitutively expressed and the latter is heat-inducible (Morano et al., 
1999).  It is unknown if and how Hsc82 association with Rtr1 is involved in the role that 
Rtr1 plays in regulating transcription elongation. 
Spn1 (Iws1, human homolog) plays an essential and highly conserved role (from 
yeast to humans) in regulating RNAPII-mediated gene expression (Pujari et al., 2010).  In 
addition to interacting with RNAPII throughout the entire reading frame of a number of 
constitutively expressed genes, Spn1 interacts with other factors such as the TATA-
binding protein (TBP) and the general transcription TFIIS (Krogan et al., 2002; Pujari et 
al., 2010).  Spn1 is thought to play an important role in forming an active transcription 
elongation complex through its interactions with RNAPII and other transcriptionally 
relevant factors such as Spt4, Spt5, Spt6, and TFIIS (Diebold et al., 2010; Pujari et al., 
2010).  Consequently, Spn1 is considered a candidate for follow-up experiments to 
further investigate its potential role in recruiting Rtr1 to RNAPII during transcription 
elongation.  
The final protein found to be enriched in the Rtr1 single purification schemes was 
Rpa49, which is the RNA polymerase I subunit A49.  Even though it is possible that 
Rpa49 could form a complex with RNAPII, perhaps at low levels, Rpa49 is not 
considered to be a primary candidate involved in recruiting Rtr1 to RNAPII during 
mRNA transcription. 
A list of the proteins detected in the present work that are potentially involved in the 
recruitment of Rtr1 to RNAPII during transcription is presented in Table 10.  
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Table 10.  Top candidate Rtr1-interacting proteins detected by MudPIT-LC/MS 
following single and double affinity purifications that are potentially involved in 
recruiting Rtr1 to RNAPII during transcription. 
Rtr1 
Interacting 
Proteins 
Cellular 
Function* 
Significance to Rtr1 
recruitment to RNAPII 
Human 
Homolog 
RNAPII 
subunits: 
Rpb1-3, Rpb5, 
Rpb8,  
Rpb10-12 
mRNA, snRNA, 
miRNA 
transcription 
1. Most consistently enriched 
Rtr1 interacting proteins 
2. Rtr1 human homolog, Rpap2, 
is recruited to human RNAPII 
by S7-P 
3. Recruitment may be mediated 
by CTD phosphorylation 
RNAPII 
(subunits 
highly 
conserved) 
Npa3 Cytoplasmic 
GTPase involved 
in RNAPII export 
to the nucleus 
1. Npa3 and Rtr1 co-locate with 
RNAPII in both the cytoplasm 
and the nucleus 
2. Npa3 and Rtr1 interact in 
human and yeast 
XAB1 
Rpt6 One of six core 
ATPases 
associated with 
the 26S 
proteasome 
The 19S regulatory subunit of the 
proteasome plays an important, 
non-proteolytic role in efficient 
transcription initiation 
p45 
PAF complex 
subunits: 
Cdc73, Ctr9, 
Leo1 
Regulation of 
RNAPII 
transcription 
1. Associates with RNAPII 
throughout the transcription 
cycle 
2. Known to serve as a scaffold 
for recruiting numerous 
transcription factors 
hPaf1 
complex 
Hsc82 Heat shock 
protein 
1. Hsc82 homolog found to 
interact with human Npa3 and 
Rtr1 
2. Hsc82 is NOT a common 
contaminant although it is a 
heat shock protein 
Hsp90 
Spn1 Essential (yet 
unknown) role in 
regulating 
RNAPII gene 
expression 
1. Involved in forming an active 
transcription elongation 
complex 
2. Interacts with RNAPII 
throughout the entire coding 
region of numerous genes 
3. Spn1 and Rtr1 share Spt5 as an 
interacting partner 
Iws1 
*Saccharomyces Genome Database (www.yeastgenome.org) 
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Figure 15.  The level of Rtr1 enrichment relative to RNAPII subunits Rpb1 and Rpb2.  
The level of enrichment was determined by dividing the LC/MS spectral counts of Rtr1 
by either Rpb1 or Rbp2 (Rpb2 enrichment relative to Rpb1 is presented as a relative 
comparator).  The level of enrichment achieved using three different purifications 
schemes is presented: Rtr1-TAP and Rtr1-FLAG single purifications; and a Rpb3-
TAP/Rtr1-HFH double purification. 
 
IV. Post-translational Modification of Rtr1 
One of the objectives of the present work was to investigate if Rtr1 post-translational 
modification is involved in its recruitment to RNAPII during transcription elongation.  
Consequently, tandem MS spectra obtained from Rtr1 single purification schemes were 
searched using the SEQUEST algorithm for potential PTMs including: phosphorylation 
(Ser, Thr, or Tyr), oxidation (Met, His), ubiquitination (Lys), methylation (Arg, Lys), and 
Sumoylation (Lys), which are some of the major PTMs involved in protein-protein 
interactions.  The results of the MS/MS analysis and SEQUEST search suggest that Rtr1 
is in fact phosphorylated at Ser217 (Figure 9).  The phosphoserine was identified from an 
MS/MS spectrum obtained from the analysis of the Rtr1 tryptic peptide 
IVENDNPSILGDFTR, which indicated a single neutral loss of 98 da from the parent 
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[M+2H]2+ ion.  The neutral loss of H3PO4 (m/z 97.977) is diagnostic for the 
phosphorylation of Ser and Thr residues as it is typically a chemically labile bond in 
collision-induced dissociation (CID) than are peptide bonds (Lehmann et al., 2007). 
The phosphorylation of Rtr1 is of particular interest in the present work as it has been 
found to directly associate with a kinase involved transcription regulation, CTDK-I 
(Fasolo et al., 2011).  Consequently, we have hypothesized that CTDK-I is responsible 
for the phosphorylation of Rtr1, and that this Rtr1 PTM is involved in its recruitment to 
RNAPII during transcription elongation.  Further experiments, of course, are required to 
support or reject this hypothesis. 
 
V. CTDK1-TAP/Rtr1-V5 Purification Scheme 
The second objective of the work presented here was to confirm the observation by 
Fasolo et al. in 2011 that Rtr1 interacts directly with CTDK-I, a regulatory kinase 
involved in RNAPII transcription (Fasolo et al., 2011).  To this end, single and double 
purification schemes were performed in S. cerevisiae that express V5-tagged Rtr1 and a 
TAP-tagged version of either Ctk1 or Ctk2, which are CTDK-I subunits.  The resulting 
samples were analyzed by Western blot, and the results of the single and double 
purifications schemes are presented in Figures 10 and 11, respectively.  For an overview 
of the single and double purification schemes, see Figure 7. 
The results of the Rtr1-V5/Ctk1-TAP and Rtr1-V5/Ctk2-TAP single purification 
experiments did not confirm the in vivo interaction between Rtr1 and CTDK-I.  Ctk1 and 
Rtr1 were detected by Western blot in the input sample, which served as a positive 
control.  In addition, Ctk1 was detected in the experimental sample; however, Rtr1 was 
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not detected (see Figure 10).  This clearly indicates that either Rtr1 does not interact with 
CTDK-I, or more probably, that the interaction between Rtr1 and CTDK-I is temporally 
brief and was consequently below the limit of detection of this approach.  Rtr1 was not 
detected in the Ctk2 input (results not shown), and consequently this portion of the 
experiment was not used for further analysis.  One possible explanation was that the S. 
cerevisiae used in this experiment (i.e. Ctk2-TAP strain) did not express a V5-tagged 
version of Rtr1, but further investigation is required to support this hypothesis. 
In an attempt to amplify the level of Rtr1, a double purification was performed that 
relied first on the immunoprecipitation of CTDK-I (via Ctk1-TAP or Ctk2-TAP) with 
IgG-sepharose followed by a second immunoprecipitation of CTDK-I/Rtr1 with anti-V5 
resin (targeting the Rtr1 V5 tag).  The results of the double purification were identical to 
those of the single purification in that both Ctk1 and Rtr1 were detected in the Ctk1 input 
sample; however, although Ctk2 was detected in the Ctk2 input sample, Rtr1 was absent 
(see Figure 11).  
The in vivo interaction between Rtr1 and CTDK-I could not be confirmed in either 
the single or double purification schemes.  However, the following section presents 
compelling evidence that CTDK-I regulates the function of Rtr1 in vivo, although it could 
not be determined if this regulation was direct or indirect.  Additionally, confirmation of 
the in vitro interaction between CTDK-I and Rtr1 is currently being investigated. 
 
VI. Effect of ctk1Δ on Rtr1 Interactions 
As discussed above, direct evidence of the interaction between CTDK-I and Rtr1 
could not be provided using Rtr1-V5/CTDK-I-TAP single and double purification 
schemes preceding analysis by Western blot.  However, in an attempt to provide evidence 
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that CTDK-I regulates Rtr1, the interactions between Rtr1, RNAPII subunits, and 
transcription-relevant factors were studied in S. cerevisiae that lacked the catalytic 
subunits of CTDK-I (ctk1Δ).  Furthermore, the effect of ctk1Δ on the level of Rtr1 serine 
217 phosphorylation was studied. 
Rtr1-TAP single purification schemes in wild-type and ctk1Δ  S. cerevisiae were 
performed preceding MudPIT-LC/MS analysis (in collaboration with Jerry Hunter). 
Following immunoprecipitation of Rtr1-TAP with IgG-sepharose resin, the interaction of 
Rtr1 with transcription-relevant proteins in wild-type S. cerevisiae were compared to 
those in ctk1Δ yeast.  The list of transcription-relevant proteins included RNAPII subunits 
(Rpb1, Rpb2, Rpb3), transcription initiation and elongation factors (Spt5, Tfg1, Dst1), 
the PAF complex subunits Cdc73, the ubiquitin ligase Asr1, which is involved RNAPII 
regulation (www.yeastgenome.org), and the histone methyltransferase Set2.  The results 
of the MudPIT-LC/MS analysis are presented in Figure 12, and it is evident that ctk1Δ 
has a significant, negative effect on the interaction of Rtr1 with RNAPII subunits and 
transcription-relevant proteins.  For example, the interaction between the largest RNAPII 
subunit, Rpb1, and Rtr1 was decreased by more than 20-fold in the ctk1Δ yeast strain 
relative to wild-type.  This trend was observed in the remaining transcription-relevant 
proteins as well, whose interactions with Rtr1 were significantly reduced in the ctk1Δ 
yeast.  This finding supports the importance of CTDK-I in the regulation of Rtr1 function 
and suggests that Ctk1 acts upstream of the Rtr1-RNAPII interaction. 
The same trend was observed for the presence of phosphorylated Rtr1 tryptic peptides 
in the absence of CTK1.  In this experiment, Rtr1 phosphorylated peptides were 
significantly reduced in ctk1Δ S. cerevisiae versus wild-type following purification of 
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Rtr1-TAP (see Figure 13).  The level of non-phosphorylated Rtr1 peptides was used to 
normalize the results across the different experiments.  The level of phosphorylated 
peptides to non-phosphorylated peptides was decreased by more than 50-fold in ctk1 
yeast versus wild-type.  These results, in addition to the finding that Rtr1 is 
phosphorylated at Ser 217 (see Figure 9), suggest that Rtr1 is a potential CTDK-I 
substrate.  
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CONCLUSIONS 
 
In 2009, Mosley and coworkers described the role of Rtr1 phosphatase in regulating a 
key step in transcription elongation, namely the transition of the RNAPII CTD 
phosphorylation state from S5-P to S2-P (Mosley, 2009).  However, the mechanism 
responsible for recruiting Rtr1 to RNAPII during mRNA transcription has not been 
uncovered.  Consequently, the focus of the work presented here was to elucidate protein-
protein interactions and post-translation modifications involving Rtr1 that may be 
involved in its recruitment to RNAPII during transcription. 
The first of two key hypotheses tested was that Rtr1 is recruited to the RNAPII 
complex during transcription elongation through an interaction with an unidentified 
protein(s), and that post-translational modification of Rtr1 or its interacting partner(s) 
may also play a role in Rtr1 recruitment.  Additionally, special attention was given to the 
PAF complex as it was previously found to interact with Rtr1 (Mosley, unpublished data) 
and has been demonstrated to associate with numerous transcription factors that are 
involved in regulating initiation and elongation (Krogan et al., 2002; Mueller and 
Jaehning, 2002; Squazzo et al., 2002).  Numerous proteins, including PAF complex 
subunits, were found to interact with Rtr1 following single and double affinity co-
purification schemes from S. cerevisiae; protein identification was by MudPIT-LC/MS 
(see Tables 5-8).   
In order to increase the confidence that the proteins detected in the affinity 
purification schemes interact with Rtr1 and RNAPII, they were subjected to data analysis 
using the computer program Scaffold.  The results of the Scaffold data analysis are 
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presented in Table 9, and several proteins were enriched in experimental sample 
preparations (relative to mock purifications which were used as negative controls) that 
could play a role in recruiting Rtr1 to RNAPII.  In addition to RNAPII subunits, seven 
proteins of particular interest were greater than 2-fold enriched in either Rtr1-RNAPII 
double purification schemes or Rtr1 single purification schemes.  These included three 
PAF complex subunits (Cdc73, Ctr9, and Leo1), the heat shock protein Hsc82, the 
GTPase Npa3 (human homolog, XAB1), the ATPase Rpt6 (human homolog, p45); and 
Spn1 (human homolog Iws1), which is involved regulating RNAPII-mediated gene 
expression.  Although it was not confirmed that these proteins recruit Rtr1 to RNAPII 
during transcription, they serve as candidates for further investigation.  For example, the 
recruitment of Rtr1 to RNAPII during transcription elongation could be studied using 
individual yeast strains that have deleted the putative proteins thought to be involved in 
the recruitment of Rtr1. 
To understand if post-translational modification of Rtr1 is involved in its recruitment 
during transcription elongation, a PTM search was performed using tandem mass spectra 
obtained from and Rtr1-TAP affinity purification.  The results of the PTM search (Figure 
9) indicate that Rtr1 was indeed phosphorylated at Ser217 (S217-P).  Follow-up 
experiments are necessary to study the dependence of S217-P on Rtr1 recruitment to 
RNAPII.  One possible set of experiments would involve mutating Rtr1-S217 to a neutral 
amino acid residue (S217A), to an acidic amino acid residue that could mimic a phospho-
group (S217D), and to a neutral but structurally similar amino acid residue (S217N).  
These Rtr1 mutants could be used to study the impact of Rtr1-S217-P on its interaction 
with RNAPII as well as the importance of S217-P on transcription elongation. 
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Fasolo and co-workers reported that the CTDK-I kinase interacts with Rtr1 in S. 
cerevisiae (Fasolo et al., 2011).  CTDK-I plays an important role in regulating RNAPII 
transcription via phosphorylation of CTD S2 and S5.  Consequently, the second 
hypothesis that was tested in the present work was that CTDK-I recruits Rtr1 to RNAPII 
during transcription, and that the recruitment of Rtr1 involves its phosphorylation by 
CTDK-I.  Unfortunately, the in vivo interaction between CTDK-I and Rtr1 could not be 
confirmed following single and double affinity purification schemes followed by Western 
blot analysis (see Figures 10 and 11).  However, indirect evidence of a functional 
relationship between CTDK-I and Rtr1 was obtained while studying the interactions 
between Rtr1, RNAPII subunits, and transcription factors in WT and ctk1Δ yeast.  
Interactions between RNAPII subunits and relevant transcription factors were 
significantly reduced in ctk1Δ (Figure 12), which indicates that CTDK-I regulates Rtr1 
function in some way.  Likewise, the negative effect of ctk1Δ in S. cerevisiae on the 
presence of phosphorylated Rtr1 suggests that Rtr1 may be a substrate for CTDK-I kinase 
activity (Figure 13).  Additional experiments are required to verify these studies, which 
could involve studying the in vitro interaction between purified Rtr1 and CTDK-I 
subunits (Ctk1 and Ctk2) as well as demonstrating that Rtr1 is a substrate for 
phosphorylation by the catalytic subunit Ctk1 (e.g. at Rtr1 Ser217). 
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